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ABSTRACT 
The objective of the first was to isolate and characterize beef muscle proteins that 
enhance nonheme iron bioavailability. Beef sirloin was cooked, lyophilized and reconstituted 
with water prior to in vitro digestion. Following centrifugation, the digest supernatant was 
sequentially ultrafiltered using lOK and 1K molecular weight cut-off membranes. Nonheme 
iron bioavailability was assessed by Caco-2 cell monolayer ^'^Fe uptake using an extrinsic 
labeling method. Cell iron uptake was 45.2% and 56.5% higher (p<0.05) with the I-kDa 
retentate (IKR) as compared to the 10-kDa retentate and 1-kDa filtrate, respectively, and 2- to 
5-fold greater than the blank (p<0.05) and iron-nitrilotriacetic acid (NTA) (p<0.001), 
respectively. Thus, the IKR was chosen for further analysis. Immobilized metal affinity 
chromatography of the 1KR yielded a series of four peaks: three distinct peaks (PI, P3, P4) 
and one with a few closely associated peaks (P2). Peptides in P1-P4 increased (p<0.00l) iron 
solubility at pH 6 as compared to the blank; 2.1, 3.6, 4.7 and 4.4-fold, respectively. When 
compared to NTA, P1-P4 were found to enhance ^"^Fe uptake by 3- to 5-fold (p<0.01). Iron 
uptake with P2 and P4 was also significantly greater than the blank (p<0.05). Gel 
electrophoresis illustrated that PI-P4 each contained many peptides ranging from 1- to 5-kDa. 
Matri.\ Assisted Laser Desorption lonization-Time of Flight analysis confirmed these 
findings. Amino acid composition analysis revealed that histidine concentration increased 
progressively in P1-P4. Our results suggest that enhancement of nonheme iron absorption by 
beef may be due to peptides produced during gastrointestinal digestion and that histidine 
content may be important. 
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The objective of the second study was to determine the effect of soy protein isolate 
(SPI) intake on iron indices and plasma total antioxidant status (TAS), and determine the 
influence of other factors on TAS in perimenopausal women. Perimenopausal women (N=69) 
were randomly assigned (double-blind) to treatment: isoflavone-rich soy protein isolate 
(SPI+; n==24), isoflavone-poor soy protein isolate (SPI-; n=24), or whey protein (control; 
n=21). Each subject consumed 40 g soy or whey protein/d for 24 weeks. Plasma TAS, serum 
ferritin, serum iron, transferrin saturation, and hemoglobin were measured at baseline, week 
12, and week 24. Treatment per se had no significant effect on serum ferritin, serum iron, and 
transferrin saturation. Time had an effect on serum ferritin (^<0.0001) and TAS (P<0.0001). 
At week 12, TAS was lower (/^0.035) in controls than SPI+, whereas no significant 
differences were found between SPI+ and SPI- at week 12 or 24. Multiple regression analysis 
revealed that at week 12, baseline TAS, alcohol intake, soy intake (soy versus control; 
P=0.016), plasma Lp(a), and dietary iron contributed to the variability (48%; P<0.0001) in 
TAS. At week 24, 46% of the variability in TAS was contributed by baseline TAS, dietary 
meat, fish, and poultry (MFP) and zinc, serum ferritin and serum estrone. SPI consumption 
had no significant effect on iron status, but our results suggest that soy intake and decreased 
iron stores may protect from oxidative stress in perimenopausal women. 
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CHAPTER I. GENERAL INTRODUCTION 
Dissertation Organization 
Two papers are included in this dissertation. The first paper entitled "Isolation and 
characterization of beef proteins that enhance nonheme iron bioavailability" presents data 
suggesting that the enhancing effect of beef on nonheme iron absorption may be due to low-
molecular weight peptides released during proteolytic digestion and that histidine may be an 
important amino acid. The second paper, "Iron indices and total antioxidant status in 
response to soy protein intake in perimenopausal women" was a subanalysis of a larger study 
designed to determine the effect of isoflavone-rich soy protein consumption on bone health 
of perimenopausal women. This study investigated whether consuming soy protein isolate 
over a period of si.x months altered the iron status and total antioxidant status of the 
perimenopausal women. The first paper will be submitted to the Journal of Nutrition and the 
second paper will be submitted to the American Journal of Clinical Nutrition for publication-
Each paper presented in this dissertation follows the format requirements of its respective 
journal. Preceding the papers is a general introduction, which includes objectives, 
hypotheses, specific aims, and significance of the two proposed studies, followed by a review 
of pertinent literature. The papers are followed by a general conclusion, which summarizes 
findings from both studies. Literature cited in the general introduction and the review of 
literature are listed alphabetically and follow the review. Literature cited in the two papers is 
listed according to the format of the respective journal at the end of each paper. 
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Introduction 
Study 1 
Hypothesis: The positive effect of beef on nonheme iron absorption is due to low 
molecular weight proteins released during proteolytic digestion, which increase the solubility 
of inorganic iron and enhance its uptake by the intestinal mucosa. 
Objective and Speciflc Aims: The objective of this study was to isolate and 
characterize beef proteins that enhance nonheme iron bioavailability by: 
1. Fractionating proteins in the digest supernatant using sequential 
ultrafiltration and immobilized metal affinity chromatography. 
2. Assessing the influence of these protein fractions on radioiron solubility 
and uptake by Caco-2 cells 
3. Determining the molecular weight and amino acid composition of these 
proteins. 
Significance of Proposed Study: Unlike heme iron, the bioavailability of nonheme 
iron is influenced by various dietary components ingested simultaneously (Cook and Monsen 
1977. Reddy et al. 1996). Meat is one of the known enhancing dietary factors on nonheme 
iron absorption. The positive influence of meat on nonheme iron absorption in humans was 
reported more than three decades ago (Layrisse et al. 1969, Bjom-Rasmussen and Hallberg 
1979). There is also evidence that the greater prevalence of iron deficiency in developing 
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countries is due to low meat intake, despite a high nonheme iron content of the diet (Hallberg 
and Rossander 1984, Gillespie and Johnston 1998). By identifying proteins in beef that 
enhance nonheme iron bioavailability, it may be possible to genetically engineer plant foods 
to contain these peptides to improve nonheme iron absorption and also to synthsize these 
peptides for use as food fortificants. 
Study II 
Hypothesis: Consumption of soy protein isolate during the menopausal transition 
attenuates menopause-associated increases in iron stores, thereby increasing antioxidant 
status in perimenopausal women. 
Objective and Specific .Aims: To determine the effect of soy protein intake on iron 
indices and plasma total antioxidant status and determine the influence of other factors on 
antioxidant status in perimenopausal women by assessing: 
1. Changes in iron status indices, such as serum ferritin, serum iron, 
transferrin saturation, total iron binding capacity, hemoglobin, and 
hematocrit. 
2. Changes in plasma total antioxidant status. 
Significance of Proposed Study: Ample information is available on the iron status 
of pre- and postmenopausal women, but the change in iron status that occurs during the 
menopausal transition, which may last for several years, has not been studied. In addition. 
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the effect of changes in body iron stores on the total antioxidant status of women during the 
menopausal transition is also not known. Oxidative status typically decreases with age 
(Jayachandran et al. 1996). whereas body iron stores generally increase, especially in women 
after menopause (Berge et al. 1994). High iron stores have been hypothesized to induce 
oxidative stress due to the ability of iron to catalyze the Haber-Weiss reaction, which 
produces the hydroxyl radical. This radical is highly reactive with all biomolecules and is 
considered to be very toxic, causing structural damage to macromolecules, such as proteins 
and lipids and breakage of DNA strands (Santanam et al. 1998). Generation of this radical in 
excess may deplete antioxidants (McCord 1993). This disturbance in the equilibrium 
between prooxidants and antioxidants may contribute to diseases, such as heart disease and 
cancer. Since epidemiological evidence suggests that increased iron stores place one at risk 
for developing heart disease (Salonen 1993, Kiechl et al. 1994) and cancer (Nelson et al. 
1994), postmenopausal women maybe at greater risk, similar to men (Sullivan 1981). 
Antioxidant defense systems, which include enzymes, plasma proteins, and dietary factors 
(Thomas 1999), react with radicals and minimize their damage (Halliwell 1993). These 
defense systems may be compromised during and after menopause and the concomitant 
increase in iron stores may increase such oxidative damage (Berliner and Heinecke 1996, 
Regnstrom et al. 1994). 
Soy protein isolate (SPI) is used extensively by the food industry, where it is 
incorporated into a variety of processed foods (Erdman and Fordyce 1989). Soy protein 
isolate is known to markedly inhibit nonheme iron absorption (Cook et al 1981, Gillooly et 
al. 1983) primarily because of its high phytic acid content (Hurrell et al. 1992) and the 
protein moeity (Lynch et al. 1994). Thus, diets poor in animal proteins that enhance iron 
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absoqDtion and diets rich in soy may be inadequate for maintaining optimal iron status in 
populations at risk for developing iron deficiency, but beneficial to groups at risk of 
developing excess iron stores. In addition, naturally occurring isoflavones in soy may have 
antioxidant properties because of their ability to donate hydrogen atoms and/or electrons 
from their hydroxyl groups to fi^ee radicals, making them less reactive (Mitchell et al. 1998). 
However, the ability of these isoflavones in vivo to affect total antioxidant status during 
menopause has not been documented. Our findings may illustrate that the consumption of 
SPl during the menopausal transition attenuates menopause-associated increases in iron 
stores and thus, provides a strategy to optimize total antioxidant status in perimenopausal 
women. 
Review of Literature 
Importance of Iron 
Iron is an essential mineral for human growth and development because it takes part 
in an array of biochemical processes vital in maintaining normal cellular function. 
Biochemical processes involving iron include electron transport (cytochromes, iron-sulfur 
proteins), handling of molecular oxygen (peroxidase, catalase), oxygen transport and storage 
(hemoglobin and myoglobin, respectively), porphyrin metabolism, collagen synthesis, 
lymphocyte and granulocyte function, and neurotransmitter anabolism and catabolism 
(Cammack et al. 1990, Pollitt and Leibel 1976). 
Body iron commonly exists in two oxidative states, the divalent ferrous and the 
trivalent ferric. Because of it's oxidative states, heme iron functions in the respiratory 
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cascade as an electron carrier as part of cytochromes in mitochondria and as a ligand for O2 
and CO: transport between tissues in the form of hemoglobin and myoglobin. Iron is also 
part of myoglobin, which stores oxygen in the tissues. Aerobic metabolism requires iron in 
the Kreb's Cycle as a cofactor of most enzymes, such as aconitase and succinate 
dehydrogenase. The nonheme iron present in these enzymes is tightly bound to the sulfur 
atoms of cysteine residues. The complexes are ot\en referred to as "iron-sulfur proteins" or 
"iron-sulfur clusters" if more than one such complex exists. Other nonheme iron-containing 
enzymes are ribonucleotide reductase, needed for deoxyribonucleic acid (DNA) synthesis, 
xanthine dehydrogenase, necessary for catabolism of the purine ring, and NADH 
dehydrogenase and coenzyme-Q reductase, required in the respiratory cascade (Brody 1994). 
Body Iron Distribution 
Total iron in the body is approximately 2 to 4 g and is distributed in several 
compartments (Figure 1). The amount of iron in the body varies with age, weight, and 
Plasma iron 
v ^ 4 m s ^ ^  
Body stores 
hemosiderin 
ferritin 
.Myoglobin 
enzymes 
300 mg 
absorptio 
Ervthrocvte iron 
2500 mg 
Figure 1. Iron distribution in the body. 
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gender. Although iron in the transport compartment accounts for a small proportion (0.8%) 
of the body's total reserve, 20 to 30 mg of iron cycles through this compartment each day 
bound to transferrin, the iron transport protein in the plasma. A large proportion (65%) of 
iron is present in circulating erythrocytes bound to hemoglobin. Tissue iron is primarily 
stored in myoglobin (10%), but a small fraction (2%) is present in a variety of iron-
containing enzymes, such as aconitase (Dall 1990, Fairbanks 1998). Storage iron (20%) is 
contained in ferritin and hemosiderin in nonheme form. Some iron is in what is termed the 
"labile pool" (2.2%). This iron is constantly recycled and does not have a specific cellular or 
anatomical location within the body (Fairbanks 1998). 
In healthy individuals, iron losses are limited. On average, obligatory daily total 
losses amount to approximately 1 mg in men and 1.5 mg in women (Cook et al. 1992). Iron 
losses primarily occur via desquamation of the gastrointestinal mucosa as ferritin-bound (0.1 
mg) (Haurani et al. 1994), gastrointestinal blood losses passed via feces bound to hemoglobin 
(0.35 mg), in biliary secretions (0.2 mg), through the urinary tract (0.08 mg), with 
desquamation of the skin (0.2 mg), and smaller amounts in sweat. A significant amount of 
iron loss is also associated with menstruation (0.7 mg/43 mL flow/d) (Fairbanks 1998). 
Iron Requirements 
Approximately 1 mg/d of iron is required by adult males and females to replenish 
obligatory iron losses described above. A 65-kg premenopausal woman requires an 
additional 0.4 mg/d to cover iron lost due to menstruation (Monsen 1988). The 
recommended dietary allowances (RDA) for iron for males and postmenopausal women is 
set at 10 mg/d and 15 mg/d for females during childbearing years. The RDA is based on the 
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premise that approximately 10% of the total dietary iron ingested is actually absorbed 
(National Research Council 1989). 
Iron Deficiency Anemia 
Dietary factors influencing the development of iron deficiency anemia include low 
dietary iron intake and/or the intake of compounds that decrease the bioavailability of iron. 
Iron deficiency may also result fi-om a low intake of other essential nutrients, such as vitamin 
A, E, Bi2, and folate. Sufficient vitamin A is necessary for the mobilization of liver iron and 
its incorporation into red blood cell hemoglobin. Vitamin E plays a vital role in protecting 
the erythrocyte from hemolysis. Vitamin B12 and folate are involved in hemoglobin 
synthesis. Non-nutritional factors, such as multiparity, the presence of chronic infection, and 
blood loss (WHO 1988) may also cause iron deficiency, which is primarily seen in 
developing countries. 
Prevalence of Iron Deficiency: Deficiency of iron and it's associated anemia affect 
more than 3.5 billion people worldwide, with greater prevalence in developing countries 
(WHO 1998). This understanding lead the World Health Organization (WHO) to classify 
iron deficiency anemia as one of its "Priority Action Areas" (WHO 1999). There are a 
number of population groups at risk for developing iron deficiency anemia. The groups 
include 1) infants and young children (6 mo to 4 yrs) because of rapid growth rates and 
insufficient reserves, 2) adolescents entering puberty due to rapidly growing tissues and an 
e.xpanding blood supply, 3) women of childbearing age due to menstrual iron losses, and 4) 
pregnant women because of the needs of the fetus and it's rapidly expanding blood volume 
and additional losses to cover childbirth (Herbert 1987, National Research Council 1989; 
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lOM 1993). Data collected from the third National Health and Nutrition Examination Survey 
showed that in the United States 11% of women aged 20 - 49 years were deficient in iron and 
that 5% suffered from iron deficiency anemia (Looker et al. 1997). In addition, it was found 
that women of Hispanic or African American descent, those of lower socioeconomic status, 
and women with greater parity were more likely to have iron deficiency anemia (Figure 2). 
In the United States, factors contributing to the prevalence of iron deficiency in infants and 
children include age, socioeconomic status, participation in the Special Supplemental Food 
Program for Women, Infants, and Children (WIC), the extent and duration of breast-feeding, 
age when milk is introduced into the diet, and the extent and duration of feeding iron-
fortified formulas (Oski 1993). 
Consequences of Iron Deficiency". Iron deficient young children display behavioral 
abnormalities, such as reduced attention span and decreased cognitive performance 
(UNICEF/^UNU/WHO/MI 1998). These abnormalities may be associated with alterations in 
dopamine synthesis and irreversible if not treated early using iron replacement therapy 
(Soemantri et al. 1985, Pollitt 1993, Dallman and Siimes 1979, Walker et al. 1996, Parks and 
Wharton 1989). A reduction in longitudinal growth rates and weight gain is also observed in 
iron deficient children. In adults, iron deficiency anemia impairs physical work capacity and 
places one at risk for non-hematologic ailments, such as abnormalities in neurologic 
response, such as memory deficits (Anezaki et al. 1992). Throughout the lifespan, iron 
deficiency impairs immune function. However, the correction of iron deficiency with iron 
supplementation may in some instances exacerbate bacterial and parasitic infections, 
especially in populations living in developing countries, since these parasitic microbes are 
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also dependent on iron for growth (Cook and Lynch 1986, Gillespie 1998, Bothwell and 
Charlton 1981). 
Iron containing enzymes were once thought to be exempt from the effects of iron 
deficiency. However, extensive animal studies have shown that this is clearly not the case 
and that iron-containing enzymes are, in fact, sensitive in varying degrees to the depletion of 
body iron. Enzymes have been found to respond differentially in a tissue-specific manner to 
iron deficiency. For example, aconitase is easily depleted even with mild iron deficiency, but 
cytochrome oxidase and catalase are far less susceptible. Iron deficiency in rats is associated 
with a ~70% reduction in the activity of iron-sulfur enzymes in the mitochondria. Decreased 
work capacity is believed to be due to impaired tolerance brought on by lactic acidosis and 
alterations in the activity of the enzyme a-glycerophosphate dehydrogenase. In addition, 
impairment of temperature regulation and decreased cold tolerance in rats may be due to a 
secondary deficiency of thyroid hormone (Beard 1998). 
Iron Excess 
In the absence of malabsorption or genetic disorders, there is believed to be no risk of 
excess body iron or developing iron overload via absorption of iron from the diet even if 
many iron-fortified foods are consumed (Hallberg et al. 1997). However, once absorbed and 
then transported out of the mucosa and into the tissues, excess iron is deposited 
predominantly as hemosiderin in reticuloendothelial cells or in the parenchymal cells of 
specific tissues. Hemosiderosis has traditionally been used to describe the condition of 
increased iron storage without associated tissue damage. Hemochromatosis has been used to 
indicate that damage caused by excess iron is present, particularly in the liver, and also that 
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iron overload is generalized with the amount of body iron greatly increased, usually to 20 to 
40 g (Fairbanks 1998). 
Excess iron or iron overload may arise for many reasons, which include disease 
states, genetic disorders, and/or transfusions. Iron overload may be caused by malabsorption 
of iron or due to a condition termed hemochromatosis, a genetic disorder characterized by 
one's inability to regulate the absorption of dietary iron (Bothwell et al. 1979). Excessive 
iron absorption occurs in hereditary hemochromatosis, excessive intake as with prolonged 
oral therapy, chronic liver disease, alcholism, or pancreatic insufficiency. Iron overload may 
also occur in individuals having sickle-cell anemia or P-thalessemia when transfusions are 
given to treat iron deficiency. Afncan Bantu siderosis is a condition that appears to have a 
genetic basis, but is primarily associated with chronically excessive intakes of iron, derived 
mainly from iron cookware (Fairbanks 1998). Frequency rates for hemochromatosis in 
African Americans appear to be consistent with the existence of a gene influencing iron 
metabolism (Gordeuk et al. 1998). 
The Hfe Protein and Hereditary Hemochromatosis: The genetic basis of iron 
overload has been of great interest recently, because a gene involved in the development of 
hemochromatosis was identified (Feder et al. 1996). The gene encodes a protein, termed Hfe, 
which may regulate cellular iron homeostasis. The protein is similar to MHC class I 
molecules and includes a signal sequence, a peptide-binding region, an immunoglobulin-like 
domain, a transmembrane region, and a small cytoplasmic portion (Feder et al. 1996). Since 
the protein spans the cell membrane, it may be capable of sensing iron concentration in the 
cytosol and, thus, influence cellular iron homeostasis. Hereditary hemochromatosis is a 
relatively common inherited autosomal recessive disorder of iron metabolism. The 
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frequency in Caucasians is approximately 1:200-l :400 and a carrier rate of approximately 
10-15% for Caucasians of northern European descent. Iron metabolism is disrupted due to 
loss of function of the Hfe protein resulting in greater deposition of iron in the tissues. 
Consequences of Excess Iron: Accumulations of iron occur primarily in hepatic 
parenchymal cells, but also in the pancreas, heart, pituitary, and the gonads (Deugnier et al. 
1993. Niederau et al. 1985). Symptoms include cirrhosis, diabetes mellitus, and cutaneous 
hyperpigmentation, but also fatigue, an increased risk of liver cancer, restrictive 
cardiomyopathy, hypothyroidism, arthropathy, and hypogonadism (Fairbanks 1998, Ascherio 
et al. 1994, Bacon and Britton 1990, Nichols and Bacon 1989, Pipemo 1998). Individuals 
with advanced hemochromatosis may also experience aberations in mental function, 
including lethargy, semnolence, confusion, and disorientation (Fairbanks 1994). 
Age-Related Iron Eixcess\ Evidence suggests that iron stores increase with age and 
that there is a positive association between increased iron stores in men and postmenopausal 
women and cardiovascular disease (CVD) (Sullivan 1981). Elevated body iron and a high 
dietary intake of iron are associated with an increased risk of myocardial infarction (Salonen 
1993). Upon resuscitation, reperfusional injury, thought to contribute to myocardial 
infarction, may result from hydroxyl radicals produced by the Fenton reaction, which 
involves the donation of one electron from ferrous iron to a molecule of hydrogen peroxide, 
generating ferric iron and • OH (Brody 1994, McCord 1996). Ascherio et al. (1994) did not 
find a clear association between dietary iron and risk for coronary heart disease in men, but 
observed an increase in the risk of myocardial infarction among men with higher heme iron 
intakes. Investigations into whether high iron stores are a risk factor for advanced 
athersclerosis and coronary heart disease failed to show an association of body iron status 
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with these conditions (Rauramaa et al. 1994, Sempos et al. 1996). Nelson et al. (1994) found 
that body iron stores and dietary iron intake were positively associated with risk of colon 
cancer. However, a study investigating the risk of epithelial cancers in sites throughout the 
body found that transferrin saturation level, iron deficiency, and iron overload were not 
related to the incidence of cancer (Herriton et al. 1995). 
Female sex hormones may be protective against CVD. Postmenopausal women are 
believed to be at greater risk of CVD because of the cessation of female hormones, increased 
ferritin, and the concomitant increase in total cholesterol, low-density lipoprotein (LDL) 
cholesterol (Berge et al. 1994, Sullivan 1981). A study investigating the hypothesis that high 
iron stores may be atherogenic and partially explain the sex difference in the incidence of 
ischemic heart disease found that transferrin, measured as total iron-binding capacity, was an 
independent negative risk factor for myocardial infarction, but not serum ferritin (Magnusson 
et al. 1994). Another study that same year provided strong evidence supporting the 
hypothesis thai body iron stores have a significant influence on differences in the 
development of atherosclerosis in between men and women. Serum ferritin was found to be 
a strong indicator of cardiovascular disease in both sexes (Kiechl et al. 1994). This raises 
serious health concerns in postmenopausal women who typically experience a rapid increase 
in iron stores, along with other risk factors, such total cholesterol, LDL cholesterol, and 
triglycerides, which also increase after menopause (Jensen et al. 1990). 
Iron Excess and Oxidative Stress: Normally, iron in the body is bound to storage or 
transport proteins and enzymes. However, in conditions where there is excess iron, fi-ee iron 
may interact with oxygen and its derivatives via the Haber-Weiss reaction (Figure 2), 
producing the free radicals (Halliwell 1993). Highly reactive molecules and radical 
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+ Of" -* Fe-^ + O2 
202" + 2H' ^ H2O2 + O2 
Fe"^ + H2O2 • OH + OH' + Fe-" 
Figure 2. The Haber-Weiss reaction. 
species contribute to the oxidative stress of cells (Cheeseman and Slater 1993). The body's 
antioxidant defense system is intended to minimize production of these radicals and the 
subsequent damage they cause to biomolecules. Antioxidant defense is conferred by various 
components (Table 1), which include enzymes and dietary factors (Thomas 1999). These 
compounds can be collectively measured as total antioxidant status. The total antioxidant 
status of normal human plasma ranges from 1.3 to 1.8 mM (Miller et al. 1993). Lower 
antioxidant status indicates a decrease in enzymes and dietary factors described above that 
are involved in antioxidant reactions, which convert harmful substances into harmless 
compunds (Figure 3). Free radicals have been shown to initiate lipid peroxidation (McCord 
1993). Low-density lipoprotein peroxidation is a marker for CVD (Berliner and Heinecke 
1996, Regnstrom et al. 1994) because of the role oxidized LDL plays in atherogenesis (Jialal 
and Devaraj 1996). The transport of oxidized LDL is altered (Steinberg 1996), and is 
thought to facilitate formation of atherogenic plaques in the endothelia of smooth muscle 
cells. 
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Table 1. Antioxidant defense systems'. 
Enzymes; 
superoxide dismutase - converts radicals to hydrogen peroxide 
catalase - detoxifies hydrogen peroxide 
glutathione peroxidase - detoxifies hydrogen peroxide and lipid peroxidases in the 
presence of reduced glutathione 
Dietary; 
alpha tocopherol - scavenges peroxyl radical intermediates 
ascorbic acid - water soluble antioxidant; acts synergistically with tocopherol 
beta-carotene - mechanism undefined 
' From Rice-Evans and Burdon 1993 
Cellular 
Respiration 
^ Superoxide 
Oxidative dismutase ^ 
Burst ^ ^ 
t 
Environmental 
Factors 
3" 'OH < 
DNA Damage Lipid Peroxidation 
Figure 3. Oxidative stress; Role of antioxidants and free iron. 
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Iron Status 
Figure 4 presents the sequential stages of iron status, iron indices, and values affected 
al each stage. Iron status may best be explained by discussing methods used in the 
assessment of iron status. 
Storage Iron Indices-. Serum ferritin is useful because it provides a precise 
quantitative measurement of the total iron in the storage compartment and it responds to 
changes in body iron sooner than other iron indices. However, this value only indicates the 
degree of iron deficiency, not iron deficiency anemia (Worwood 1979). Approximately 
1 ng/L serum ferritin corresponds to 8-10 mg of storage iron in the average adult. Some 
disadvantages of the serum ferritin indice are that it is influenced by age, sex, and the 
presence of chronic disease states, such as infection, inflammation, and certain neoplastic 
diseases. In pregnancy, serum ferritin concentrations may vary daily by 25% (Beard 1994) 
and may fall by 20 \xs/L during the first 30 weeks of pregnancy (Kaufer and Casanueva 
1990). Serum ferritin concentration typically remains lower in women of childbearing age 
than in men, but after menopause serum ferritin increases. This increase usually persists 
through the fifth and sixth decades of a woman's life, typically approaching that of males. 
Although results vary, medications and other prescriptions have been shown to influence 
serum ferritin concentration. Mooij et al. (1992) found that serum ferritin concentration 
decreased in response to routine oral contraceptive use. On the contrary, the duration of 
menses influenced serum ferritin, but that contraceptive use did not (Soustre et al. 1986). 
To gauge the sufficiency of iron reserves and to determine the presence or iron 
deficiency anemia, serum ferritin concentration is often combined with other measurements, 
such as the transferrin receptor. The transferrin receptor assay is a more recent method. 
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I- •POSITIVE BALANCE-
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Transferrin saturation 
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Balance 
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Microcytic/ 
HypochrwDic 
Figure 4. Sequential stages of iron status. From Herbert, V: Everyone should be tested for iron disorders {J Amcr Did Assoc 
92:1502, 1992). 
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which reflects tissue iron sufficiency. The serum transferrin receptor concentration allows 
for the early detection of iron deficiency and to distinguish iron deficiency anemia from 
anemia caused by chronic disease states, such as from infection, inflammation, and 
malignancy (Ferguson et al. 1992, Cook et al. 1993, Baynes 1996). In healthy adults, the 
daily variation of the transferrin receptor fi-agment concentration is less than that of serum 
ferritin (Cooper and Zlotkin 1996). Carriaga et al. (1991) illustrated that by combining the 
serum transferrin receptor value with serum ferritin measurements, the entire spectrum of 
iron status can be assessed during pregnancy. When tissue iron needs are not being met 
synthesis of the transferrin receptor is upregulated. Skikne et al. (1990) found that serum 
receptor fragment levels remained normal during the period of storage depletion, but that 
once the serum ferritin concentration fell below 12 ng/L the serum receptor began to rise and 
continued to do so as deficiency persisted. 
Transport Iron Indices: Serum iron is usually measured in tandem with its specific 
transport protein, transferrin. Transferrin saturation is measured via total iron-binding 
capacity (TIBC), which is the amount of iron that can be bound by plasma transferrin. A 
useful index of transport iron is plasma iron expressed as a percentage of TIBC; this is 
referred to as transferrin saturation. The major limitation with the transferrin saturation value 
is that there is wide diurnal variation; in healthy subjects the concentration may vary by 
100% during a 24-h period (Nilson-Ehle 1990). 
Red Blood Cell Indices : Measurement of hemoglobin concentration in whole blood is 
often done to screen for iron-deficiency anemia since a low hemoglobin concentration is 
associated with microcytic hypochromia, a characteristic of iron-deficiency anemia. 
Although hemoglobin concentration is useful as an index of iron status it is influenced by 
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many factors. Some factors that affect hemoglobin values are age, sex, race, the presence of 
chronic infection, inflammation, hemorrhage, protein-energy malnutrition, thalassemia 
minor, hemoglobinopathies, pregnancy, plasma expansion, and the deficiency of some 
vitamins, such as vitamin B12 or folate (Johnson-Spear and Yip 1994). Other factors 
affecting hemoglobin concentration are normal diurnal variation and cigarette smoking. 
Hemoglobin values decrease only after iron stores have been fully depleted. There is also 
considerable overlap in the hemoglobin values of normal non-anemic and iron-deficient 
individuals. When hemoglobin falls below 14 or 15.5 g/dL in women and men. respectively, 
iron deficiency anemia may be present. 
The hematocrit value is determined by measuring the volume of packed red blood 
cells; usually the value is expressed as percent volume packed red blood cells or packed cell 
volume. Since the hematocrit is influenced by all of the factors that affect hemoglobin and is 
highly susceptible to technical errors (i.e. poorly packed red blood cells, improper mixing of 
the blood and tube components, and elevated white blood cell counts) the usefulness of the 
hematocrit is limited. Early in iron deficiency, a slightly reduced hemoglobin concentration 
may coexist with a near-normal hematocrit. 
Once the hematocrit and other iron indices have been determined, the mean red blood 
cell volume (MCV). The MCV is a measure of the average size of the red blood cell. Since 
the red blood cell is unaffected by plasma dilution and because the anemia of iron deficiency 
is microcytic, the MCV is a relatively specific index for iron deficiency. Infection, chronic 
inflamation, thalessemia minor, and lead poisoning influence MCV and may, therefore, 
diminish its usefulness. The main limitation of MCV, as is the case with other iron status 
indices, is the period of time after onset of iron deficiency for the value to become abnormal. 
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In addition, the presence of concomitant vitamin Bn or folate deficiency should also be of 
concern, since a deficiency of either of these two nutrients may also result in anemia. 
Models Used in the Assessment of Iron Status: A variety of laboratory techniques 
may be used to assess iron status when screening for iron deficiency and iron overload. 
Typically, to improve accuracy, screening involves the use of a combination of methods 
(Cook et al. 1976. Cook et al. 1992). For example, three models or techniques have often 
been used in the assessment of iron deficiency. The "ferritin model", uses serum ferritin, 
transferrin saturation, and erythrocyte protoporphyrin. Iron deficiency is confirmed if two of 
the three indices are abnormal. The "MCV model" uses the mean volume of the red blood 
cell instead of serum ferritin, but requires that two of the three indices be abnormal for iron 
deficiency to be confirmed. Use of the MCV model with other values, such as serum iron, 
transferrin receptor, hemoglobin, and hematocrit, allows one to more specifically define the 
stage and extent of iron deficiency and detect the presence of iron deficiency anemia (Gibson 
1990, Cook et al. 1992, Cook et al. 1994). The MCV model incorporates serum ferritin, 
which is useful because it provides a precise quantitative measurement of the total iron in the 
storage compartment and it responds to changes in body iron sooner than other iron indices. 
The third technique, the "change in median hemoglobin concentration", is often used for final 
confirmation after first using one of the two models above (Expert Scientific Working Group 
1985). 
Iron Bioavailability 
Iron balance is maintained primarily by regulation of heme and nonheme iron 
absorption and transport throughout the small intestine (Figure 5). Healthy individuals 
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absorb approximately 5 to 10% of dietary iron, whereas those who are iron deficient absorb 
from 10 to 20% (Fairbanks 1998). Iron absorption depends not only on an individual's iron 
status (Lynch et al. 1989) and the amount of iron ingested, but also by its availability 
(Hallberg 1981, Carpenter and Mahoney 1992). Iron absorption is influenced by various 
GLT MUCOSAL CELL BLOOD 
transport 
protein 
Nonlicmc Fc tissues 
Nonlicmc Fc Fc 
storase 
protein Fc bone marro\> 
eryth ropoeisis 
Heme Fc 
Heme Fe 
Figure 5. Overview of iron absorption and transport. 
intraluminal factors, such as transit time, achlorhydria, steatorrhea, malabsorption 
syndromes, precipitation by alkalinization, phosphates, riboflavin deficiency, phytic acid, 
ingested alkaline clays, and antacid preparations (Fairweather-Tait et al. 1992, Groff et al. 
1995). Impaired iron absorption in achlorhydric or gastrectomized subjects may be related to 
decreased solubilization and chelation of the ferric iron in food. 
Heme and Nonheme Iron: Iron in foods exists in heme and nonheme forms. Heme is 
found primarily in animal tissue, whereas, nonheme is found in both animal and vegetable 
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foods (Fairbanks 1998, Kalpalathika et al. 1991) (Figure 6). The nonheme iron from a 
variety of vegetable and animal foods, once liberated from its food matrix, becomes part of 
Heme Iron Nonheme Iron 
• found primarily in animal • Found primarily in grains 
tissue and vegetables, but some in 
animal tissues 
• 10-15% of total dietary iron • 85-90% of total dietary iron 
• - 25% absorption • 10% absorption 
- ~ 1/3 of total iron absorbed - -2/3 of total iron absorbed 
• not affected by dietary • highly affected by dietary 
factors factors 
• affected by iron status • affected by iron status 
• Fe2->Fe'-
Figure 6. Heme and nonheme iron absorption. 
what is termed the "nonheme iron pool" in the gastrointestinal lumen. Heme iron comprises 
what is termed the "heme iron pool". In this discussion, heme iron or nonheme iron refers to 
iron coming from their respective pools. 
Heme iron contributes only 10-15% of the total iron in Western diets (Hallberg and 
Rossander 1982), but because it is highly bioavailable it accounts for about one-third of the 
total iron absorbed per day (Bezkorovainy 1980). About 50 to 60% of the iron in meat, fish, 
and poultry is heme iron, which may be close to 30% available (Fairbanks 1994, Monsen 
1988). Heme iron is absorbed by a mechanism that differs from that for nonheme iron. Most 
of the heme ingested is in the form of hemoglobin and myoglobin, which is absorbed directly 
by mucosal cells following the removal of the globin via proteolytic duodenal enzymes or the 
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protein portion may be removed within the mucosal epithelium (Fairbanks 1994). Once 
inside the cell, iron is liberated from heme by the enzyme hemeoxygenase before entering the 
plasma as Fe" bound to transferring (Uzel and Conrad 1998). Dietary heme iron absorption 
is relatively unaffected by enhancers and inhibitors, such as ascorbic acid and phytates, 
respectively. 
Nonheme iron absorption is influenced by a variety of factors that affect its 
bioavailability (Narasinga-Rao 1981, Monsen 1988, Reddy et al. 1996, Fleming etal. 1998). 
Nearly all of the iron in plants is nonheme iron, but a large proportion of the iron in meat is 
also nonheme iron (Hallberg 1980). The availability of nonheme iron in plant foods such as 
beans, peas, com, bread, and rice is relatively low, up to 10%. Furthermore, although 
nonheme iron is the major fraction of total dietary iron, its absorption rate may be only 1 to 
7% from vegetable staples such as rice, wheat bran, and maize when consumed alone 
(Bothwell et al. 1979). 
Iron Absorption and Transport: The divalent ferrous (Fe"") is more soluble than the 
trivalent ferric (Fe''*) at the alkaline pH of intestinal environment and thus, Fe"~ is believed to 
cross the mucus layer more readily to reach the brush border of the intestinal epithelia. The 
absorption of iron generally occurs via mucin by one or more proteins on the luminal surface 
of the mucosal epithelium throughout the small intestine (Conrad et al. 1993), but absorption 
is most efficient in the duodenum. Two major recently identified iron transporters, 
independent of transferrin and TfR, are the H+-coupled divalent cation transporter-1 (DCT-1) 
and Nramp2, in the rat and human, respectively (Gunshin et al. 1997, Fleming et al. 1997, 
Fleming et al. 1998). Because of the similarity between these two transporters they are 
thought to be one in the same protein and have, together, been renamed as the divalent metal 
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transporter (DMT-I). The process by which DMT-1 modulates the rate of iron absorption by 
the intestinal mucosa has not yet been completely elucidated. Analysis of the expression of 
mRNA indicates that DMT-1 is produced in the proximal small intestine epithelia, but in 
other cells of the body as well. Transport mediated by DMT-1 is active and requires proton 
coupling, dependent on the membrane potential of the cell. A wide array of essential 
divalent metal ions can be transported into the cell by DMT-1. DMT-1 is abundant on the 
tips of villi of the duodenum and it is likely to be the primary transporter of dietary iron into 
the enterocyte (Gunshin et al. 1997, Fleming et al. 1999). 
Iron is also believed to enter the mucosal cell as either an iron-Nramp2 or iron-
integrin complex that is internalized and successively complexed with mobilferrin and then 
transferred to paraferritin, which functions as the cytosolic iron-transport protein that delivers 
iron to the serosal side of the cell (Umber et al. 1998). Once iron reaches the interior of the 
serosal wall the iron is released as Fe"', oxidized by ceruloplasmin to Fe^*, taken up by 
transferrin in the subendothelial capillary network for transport to the liver and then to the 
rest of the body. The pathway for heme iron absorption differs from that for nonheme iron. 
Heme iron is absorbed by the mucosa and released from protoporphyrin by heme oxygenase 
before binding to paraferritin in the cytosol. Once bound to paraferritin, the iron from heme 
is transported as described above. 
The following are a number of proteins believed to be involved in cellular acquisition 
of iron throughout the body: 1) an iron-binding protein which is a trimer of 54-kDa subunits, 
2) a P3-integrin of approximately 160-kDa that spans the cell membrane and consists of two 
subunits, 3) the Hfe protein that spans the cell membrane which is 44-kDa and functions 
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together with P2-microgIobulin, a small protein of approximately 11-kDa, and 4) natural 
resistance-associated macrophage protein 2 (Nramp2), a transmembrane protein. 
Factors Affecting Nonheme Iron Bioavailability 
Although absorption from the nonheme iron pool constitutes a major fraction of daily 
iron intake, unlike heme iron, its absorption depends on the presence of a variety of dietary 
components ingested simultaneously (Monsen 1988, Hallberg et al. 1989, Reddy et al. 1996, 
Fleming et al. 1998). Ascorbic acid (Cook and Monsen 1977, Hallberg et al. 1988, Hurrell et 
al. 1989, Lynch and Cook 1980) and muscle tissue from meat, fish, and poultry (Cook and 
Monsen 1976, Bjom-Rasmussen and Hallberg 1979, Layrisse et al. 1969) enhance nonheme 
iron absorption, whereas phytic acid (Gillooly et al. 1983, Hallberg et al. 1987), polyphenols 
(Disleret al. 1975, Gillooly et al. 1983), and soy (Cook et al. 1981, Lynch et al. 1994) inhibit 
nonheme iron absorption. The mixture of foods eaten by humans and the interplay of 
nutrients and non-nutrients affects nonheme iron absorption in complex ways. In an effort to 
better understand this interplay, researchers have developed algorithms for calculating the 
bioavailability and absorption of nonheme iron (Reddy 2000, Hallberg and Hulthen 2000). 
Ascorbic Acid: The ability of ascorbic acid to effectively increase nonheme iron 
absorption in humans is well documented (Cook and Monsen 1977, Hallberg and Rossander 
1984. Hallberg et al. 1989). The ability of ascorbic acid to reduce iron and to form stable 
soluble complexes, even under alkaline conditions, are known to be responsible for its 
enhancing effect (Conrad and Schade 1968, Lynch and Cook 1980). Cook et al. (1972) 
found that the addition of 500-mg ascorbic acid to a maize meal resulted in a 6-fold increase 
in iron absorption. Concomitant fortification of iron and ascorbic acid has proven more 
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effective than iron alone in improving iron nutrition in countries where iron deficiency 
anemia was endemic (Sayers 1973, 1974a, 1974b). However, its susceptibility to oxidation 
in the presence of metal ions limits its use in foods to improve nonheme iron absorption 
(Monsen 1988, Cook and Monsen 1977, Hallberg et al. 1989, Lynch and Cook 1980). 
Although ascorbic acid is known to increase nonheme iron absorption, ascorbic acid 
supplementation with complex meals has only been shown to moderately improve serum 
ferritin concentrations after 10 to 16 weeks (Hunt et al. 1994, Cook et al. 1984). 
Meat: Meat is an important component of a balanced diet and plays a substantial role 
in iron nutrition. Low intake of meat and meat products contributes to a higher incidence of 
iron deficiency in some populations despite a high iron intake (Hallberg and Rossander 1984, 
Gillespie and Johnston 1998). Meat offers not only highly absorbable heme iron, but also is 
known to enhance nonheme iron absorption. The positive influence of meat on nonheme 
iron absorption in humans has been reported by a number of researchers (Hallberg and 
Rossander 1984, Cook and Monsen 1976, Gordon and Godber 1989, Bjom-Rasmussen and 
Hallberg 1979, Engelmann et al. 1998, Layrisse et al. 1969, Cook et al. 1982). Layrisse et al. 
(1968) initially reported that animal tissue enhanced nonheme iron absorption and in a later 
study (Martinez-Torres and Layrisse 1970) confirmed this observation, noting that the 
addition of fish muscle tissue enhanced nonheme iron absorption from a meal of black beans. 
This positive influence of animal tissue has been attributed to an unknown "factor" 
hypothesized to prevent iron from polymerizing and maintain iron in a stable soluble form 
suitable for absorption (Carpenter and Mahoney 1992). In vitro studies have shown that the 
factor(s) in meat may have a reducing capability that is similar to ascorbic acid, glutathione, 
and cysteine (Kapsokefalou and Miller 1991). 
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The effect of animal tissue on nonheme iron absorption was later found not to be due 
to differences in the quality and quantity of the proteins (Cook and Monsen 1976, Bjom-
Rassmussen and Hallberg 1979, Cook and Monsen 1975). High quality proteins were shown 
to have dissimilar effects on nonheme iron absorption. Animal tissues, such as pork, beef, 
chicken, liver, lamb, and fish had similar enhancing effects on iron absorption, whereas, egg, 
milk, cheese, and ovalbumin protein had no enhancing effect. Researchers have also 
suggested that the amino acid profile of proteins was responsible for the differences observed 
in iron absorption (Kroe et al. 1963, Van Campen and Gross 1969, Bjom-Rassmussen and 
Hallberg 1979). Histidine and lysine were found to increase iron absorption when given 
concurrently with ^''Fe in rat intestinal segments (Van Campen and Gross 1969), which was 
surprising because of the known differences between human and rats (Layrisse et al. 1984). 
The decarboxylation of histidine and removal of the a-amino residue fi-om lysine caused 
these amino acids to no longer enhance FeCb absorption in rats (Van Campen 1973). 
The influence of meat on nonheme iron absorption was also attributed to the 
stimulation of gastric acid secretion (Korman et al. 1971). However, the observation that 
nonheme iron absorption also increases immediately following beef consumption in 
achlorhydric patients did not support this hypothesis (Bjom-Rassmussen and Hallberg 1979). 
Dietary saturated fat, such as stearic acid has also been found to enhance nonheme iron 
absorption and utilization (Johnson et al. 1992, Lukaski et al. 1993). Kapsokefalou and 
Miller (1993) suggested that the effect might involve an interaction between the lean and fat 
fractions in beef The enhancement of nonheme iron absorption by meat was later 
hypothesized to involve many different mechanisms including both luminal pH and chelation 
(Zhang et al. 1990). 
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A controversy exists as to whether proteolytic digestion is necessary to release the 
component in meat responsible for enhancing nonheme iron absorption. Cellular meat 
proteins may possess nonheme iron absorption-enhancing capabilities because of certain 
amino acids and intermediary products, likely produced during gastrointestinal digestion. 
These substituents may chelate and solubilize iron, thereby facilitating nonheme iron 
absorption by the gut mucosa (Glahn and Van Campen 1997). Iron solubility has been 
shown to be influenced by the peptic and pancreatic digestion of meat (Slatkavitz and 
Clydesdale 1988). Cysteine and reduced N-terminal cysteinyl-peptides released during 
digestion have been hypothesized to be responsible for the positive effect on nonheme iron 
absorption (Glan and Van Campen 1997, Taylor et al. 1986, Garcia et al. 1996). On the 
contrary, findings indicate that the factor in meat responsible for enhanced nonheme iron 
absorption may not be released during gastrointesinal digestion (Au and Reddy 1997, 
Carpenter and Mahoney 1989). Since proteolytic digestion of meat was shown not to be 
necessary to increase dialyzable and soluble iron, this may indicate that meat contains 
enhancing factors, capable of solubilizing iron, that are independent of proteolytic digestion 
(Kane and Miller 1984, Carpenter and Mahoney 1989). A clear understanding of the positive 
effect of meat has not yet been achieved, but data suggest that proteins and/or their 
constituents in meat interact with nonheme iron and maintain its solubility. 
Phenolic Compounds: Phenolic compounds in plant foods are known inhibitors of 
iron absorption (Disler et al. 1975, Rossander et al. 1979, Gillooly et al. 1983, Brune et al. 
1989, Hurrell et al. 1999). Tea and coffee reduce iron absorption substantially in proportion 
to the amount ingested. One theory is that inhibition of nonheme iron absorption by tea is 
caused by temporary damage to the intestinal mucosa (Mitjavila et al. 1977). However, 
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South et al. (1997) demonstrated that the effect is primarily due to the chelation of metallic 
iron by tannins, resulting in the formation of insoluble complexes. Tea is more potent 
inhibitor of nonheme iron absorption than coffee and may reduce iron absorption by 
approximately 60%. A recent study by Hurrell et al. (1999) found that a number of 
polyphenol-containing beverages, such as herb teas, black tea, coffee, and cocoa are potent 
inhibitors of nonheme iron absorption. 
Phytic Acid: Phytic acid (myoinositol hexaphosphate) is found in seeds, cereal 
grains, and legumes in which it functions as a major phosphorus storage compound. Phytic 
acid is present at 1 to 5% w/w of legumes, cereals, and nuts and has been identified as a 
major inhibitor of nonheme iron absorption by plant foods. The function of phytic acid may 
be to sequester metal ions needed later for plant growth and to prevent them from inducing 
oxidative spoilage. Phytic acid chelates multivalent metal ions, especially iron, calcium, and 
zinc, and forms insoluble salts that have poor bioavailability in the gastrointestinal tract 
(Zhou and Erdman 1995). McCance et al. (1943) found that phytic acid inhibited nonheme 
iron absorption. As little as 5 to 10 mg of phytic acid can reduce nonheme iron absorption by 
50%. In addition, populations consuming diets of vegetable origin consisting mostly of 
legumes and cereal grains having appreciable quantities of phytic acid have a higher 
prevalence of iron deficiency anemia (Hallberg and Rossander 1984, Shaw et al. 1995). Of 
particular importance is the observation that the addition of meat or ascorbic acid to such a 
diet reverses the iron-chelating effect of phytate (Hallberg 1987). 
Soybeans possess high amounts of phytic acid; soybeans contain approximately 1.4% 
vv/w phytic acid (Graf and Eaton 1990). Hurrell et al. (1992) determined that there was an 
increase in nonheme iron absorption with a decrease in the phytic acid content of soy protein 
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isolates. The amount of phytic acid may have a significant efTect on nonheme iron 
absorption; less than 0.3 mg phytic acid per gram soy protein isolate had a strong inhibitory 
affect on nonheme iron absorption in human subjects consuming a semipurified test meal 
(Hurrell et al. 1992). Lynch et al. (1994) determined that there are two major inhibitors of 
human nonheme iron absorption present in soy protein isolate, phytic acid and a protein-
related moiety (7S conglycinin). They were able to demonstrate that purified and 
dephytinized 7S conglycinin had an inhibitory effect approximately equal to that of phytate. 
Calcium: The effect of calcium on nonheme iron absorption is controversial. When 
calcium intake increased from 300-1,200 mg/day over a period of 5 days no significant affect 
on nonheme iron absorption was observed (Reddy and Cook 1997). However, the addition 
of both calcium and phosphate decreased the absorption of nonheme iron (Cook et al. 1991), 
but if calcium was provided alone, this inhibitory effect was not seen. The inhibitory effect 
of supplemental calcium was also demonstrated when milk and ferrous sulfate were ingested 
simultaneously (Hallberg et al. 1991). Sokoll and Dawson-Hughes (1992) studied the effect 
of supplemental calcium on the iron stores of healthy premenopausal women. They found 
that over a 12-week period I g supplemental calcium with meals did not influence plasma 
ferritin concentration. The effect may be due to the binding of iron by the insoluble calcium 
phosphate complex formed in the alkaline environment of the small intestine, resulting in a 
decrease in the bioavailability of iron (Morck and Cook 1981). However, the effect may also 
involve such variables as meal type (single or complex), normal calcium content of the meal, 
and the phytate content of the meal (Lynch 1997). 
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Methods of Assessing Nonheme Iron Bioavailability 
The absorption of nonheme iron is influenced by many factors in the diet and, hence, 
the bioavailability of iron in the presence of a variety of factors is of particular importance to 
researchers in the field of iron nutrition. A relatively inexpensive and valid assay to measure 
the bioavailability of nonheme iron would advance understanding of the combined effect of 
dietary factors most influencing nonheme iron absorption. 
Several methods have been used to assess nonheme iron bioavailability. Forbes et al. 
(1989) reviewed some of these methods and discussed their validity to human iron 
absorption. Rat models are appealing for in vivo studies, but no suitable small animal model 
is currently available for studying human nonheme iron absorption. In addition, 
extrapolation of iron absorption data from rats to humans is questionable since factors shown 
to influence nonheme iron absorption in rats do not in humans (Reddy and Cook 1991). In 
vitro studies are appealing because of the lower cost, decreased complexity, and less time 
consuming. The equilibrium dialysis method is the most common method used to assess iron 
bioavailability (Miller et al. 1981, Shen et al. 1994). Bioavailability as based on solubility or 
dialyzability alone has been shown to not accurately reflect uptake by the intestinal mucosa 
(Gangloff et al. 1996a, Miller and Bemer 1989). Since foods are comprised of many 
different compounds, a nonheme iron absorption model that allows one to test many 
combinations of substances and individual compounds under more physiologic conditions 
would facilitate identification of factors responsible for enhancing nonheme iron absorption. 
The Caco-2 cell line appears to be a good model to measure physiological iron 
absorption (Garcia et al. 1996, Glahn et al. 1996, Au and Reddy 2000). The Caco-2 cell is a 
human colon carcinoma cell, which undergoes spontaneous differentiation in cell culture to 
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form polarized epithelial cell monolayers with many of the characteristics of enterocytes 
(Pinto et al. 1983). Caco-2 cells have been shown to be useful in measuring nonheme iron 
absorption under a variety of conditions (Halleux and Schneider 1991, Alverez-Hemandez et 
al. 1991, Gangloff et al. 1996a and b, Glahn et al. 1996, Glahn and Van Campen 1997, Glahn 
et al. 1998, Glahn et al. 1999). Many factors that influence Caco-2 cell growth and nonheme 
iron uptake have been studied (Jumarie and Malo 1991. Halleux and Schneider 1994, 
Alverez-Hemandez et al. 1994, Han et al. 1994, Han. et al. 1995, Glahn et al. 1995, Gangloff 
et al. 1996b, Arredondo et al. 1997, Alverez-Hemandez et al. 1998). Use of the Caco-2 cell 
model has been shown to be a valid tool to study human nonheme iron bioavailability, 
including the enhancing effect of meat on nonheme iron absorption (Garcia 1996). In 
addition, iron absorption by Caco-2 cells correlates well to human iron absorption 
measurements (Au and Reddy 2000). 
Use of the Caco-2 cell model allows one to determine the interaction among various 
food components individually and collectively, as mixtures of nutrients and non-nutrients, on 
nonheme iron absorption. One of the advantages of the Caco-2 cell model is that it can 
reasonably accommodate vast combinations of foods and components and a multitude of 
slight adjustments in concentration when individual compounds are studied. In addition, use 
of the Caco-2 cell model to study iron absorption is relatively inexpensive when compared to 
human studies or animal models. 
Recent studies showing the validity of using the Caco-2 cell model to study human 
iron bioavailability, including the enhancement of meat on nonheme iron absorption (Garcia 
et al. 1996, Glahn et al. 1996, Glahn et al. 1999), prompted us to use this cell line to identify, 
and thereafter characterize, beef proteins that enhance nonheme iron bioavailability. 
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CHAPTER 2. ISOLATION AND CHARACTERIZATION OF BEEF PROTEINS 
THAT ENHANCE NONHEME IRON BIOAVAILABILITY 
A paper to be submitted to Journal of Nutrition 
James H. Swain', Louisa B. Tabatabai", Manju B. Reddy' 
RUNNING TITLE: Beef proteins enhance nonheme iron bioavailability 
ABSTRACT The objective was to isolate and characterize beef muscle proteins that 
enhance nonheme iron bioavailability. Beef sirloin was cooked, lyophilized and 
reconstituted with water prior to in vitro digestion. Following centrifligation, the digest 
supernatant was sequentially ultrafiltered using lOK and IK molecular weight cut-off 
membranes. Nonheme iron bioavailability was assessed by Caco-2 cell monolayer '''Fe 
uptake using an extrinsic labeling method. Cell iron uptake was 45.2% and 56.5% higher 
(p<0.05) with the 1-kDa retentate (IKR) as compared to the 10-kDa retentate and 1-kDa 
filtrate, respectively, and 2- to 5-fold greater than the blank (p<0.05) and iron-nitrilotriacetic 
acid (NTA) (p<0.001), respectively. Thus, the IKR was chosen for further analysis. 
Immobilized metal affinity chromatography of the 1KR yielded a series of four peaks: three 
distinct peaks (PI, P3. P4) and one with a few closely associated peaks (P2). Peptides in Pl-
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P4 increased (p<0.001) iron solubility at pH 6 as compared to the blank; 2.1, 3.6, 4.7 and 4.4-
fold, respectively. When compared to NTA, P1-P4 were found to enhance ^''pe uptake by 3-
to 5-fold (p<0.01). Iron uptake with P2 and P4 was also significantly greater than the blank 
(p<0.05). Gel electrophoresis illustrated that PI-P4 each contained many peptides ranging 
from 1- to 5-kDa. Matrix Assisted Laser Desorption lonization-Time of Flight analysis 
confirmed these findings. Amino acid composition analysis revealed that histidine 
concentration increased progressively in P1-P4. Our results suggest that enhancement of 
nonheme iron absorption by beef may be due to peptides produced during gastrointestinal 
digestion and that histidine content may be important. 
KEYWORDS: • Beef proteins • nonheme iron • bioavailability • ultrafiltration • 
Caco-2 cells • histidine 
INTRODUCTION 
Iron absorption in humans depends on an individual's iron status (Lynch et al. 1989a and 
1989b), dietary iron intake (Bjom-Rasmussen et al. 1974), and its bioavailability (Hallberg 
1981, Carpenter and Mahoney 1992). Nonheme iron typically constitutes the major fraction 
of daily iron intake, but unlike heme iron, its absorption is influenced by various dietary 
components (Layrisse et al. 1969, Narasinga-Rao et al. 1981, Cook and Monsen 1977, 
Monsen 1988, Reddy et al. 1996). Animal tissue (Layrisse et al. 1969, Cook and Monsen 
1976, Hurrell et al. 1988) and ascorbic acid (Hallberg et al. 1989, Lynch and Cook 1980) 
enhance, whereas many plant factors, such as phytate (Gillooly et al. 1983, Hallberg et al. 
1987, Reddy etal. 1996), polyphenols (Disleretal. 1975, Gillooly et al. 1983), and soy 
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protein (Cook et al. 1981, Lynch et al. 1994) inhibit nonheme iron absorption. Many 
researchers have reported the positive influence of meat on nonheme iron absorption in 
humans (Layrisse et al. 1969, Bjom-Rasmussen and Hallberg 1979, Cook et al. 1982, 
Hallberg and Rossander 1984, Engelmann et al. 1998) and the greater prevalence of iron 
deficiency in developing countries has been attributed to a diet low in meat, despite a high 
nonheme iron content (Hallberg and Rossander 1984, Gillespie and Johnston, 1998). 
The enhancing effect of meat is attributed to unknown factor(s), usually known as "meat 
factor(s)", that may maintain iron in a soluble form, thereby increasing its bioavailabilty 
(Carpenter and Mahoney 1992). Not all animal proteins have the same enhancing effect. For 
example, pork, beef, chicken, liver, lamb, and fish enhance nonheme iron absorption, but 
egg. milk, cheese, and ovalbumin protein do not (Layrisee et al. 1969; Cook and Monsen 
1975, Cook and Monsen 1976, Bjom-Rassmussen and Hallberg 1979). The influence of 
meat on nonheme iron absorption was initially attributed to the stimulation of gastric acid 
secretion (Korman et al. 1971). However, reducing components (Kapsokefalou and Miller 
1991), stearic acid (Johnson et al. 1992, Lukaski et al., 1993), certain amino acids (Van 
Campen and Gross 1969, Marinez-Torres et al. 1981, Taylor et al. 1986, Glahn et al. 1997), 
and peptides released during proteolytic digestion (Kane and Miller 1984, Slatkavitz and 
Clydesdale 1988) have also been suggested to play a role in the enhancement of nonheme 
iron absorption. 
Data on the factor(s) in meat responsible for the enhancement of nonheme iron 
absorption are inconclusive, possibly because of differences in the methodologies employed. 
In vivo, rat models have been used to study the influence of meat on nonheme iron 
absorption (Gordon and Godber 1989), but extrapolation of the data from rats to humans is 
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questionable since some factors shown to influence nonheme iron absorption in humans have 
been shown to have marginal or no effect in rats (Reddy and Cook 1991). An in vitro 
method, using equilibrium dialysis is the most common technique used to assess iron 
bioavailability (Miller et al. 1981; Shen et al. 1994). However, bioavailability based on 
solubility or dialyzability alone may not accurately reflect uptake by the intestinal mucosa 
(Miller and Bemer 1989; Gangloff et al. 1996). The identity of the factor(s) in meat 
responsible for enhanced nonheme iron absorption remains poorly characterized. 
Caco-2 cell iron uptake is of increasing interest in nutritional studies. Caco-2 cells, a 
human colon adenocarcinoma cell line, spontaneously differentiate into polarized monolayers 
with well-developed brush borders and exhibit many of the morphological and biochemical 
characteristics of enterocytes (Pinto et al. 1983). Caco-2 cell iron uptake is a physiological 
measure of iron absorption and shown to correlate well to human iron absorption when many 
dietary factors are tested (Au and Reddy 2000). Recent studies using this cell line to study 
iron bioavailability, including the enhancing effect of meat on nonheme iron uptake (Garcia 
et al. 1996, Glahn et al. 1996, Glahn and Van Campen 1997, Glahn et al. 1999), prompted us 
to use this in vitro model in an attempt to isolate and characterize beef proteins that enhance 
nonheme iron bioavailability. 
MATERIALS AND METHODS 
All of the enzymes and chemicals were obtained from Sigma Chemical Company (St. 
Louis, MO) unless noted otherwise. Deionized (DI) water was used throughout the study and 
reagents were prepared fresh before use. Beef samples were stored under nitrogen 
atmosphere at -80°C. 
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Sample Preparation. A total of 1.5 kg of lean beef, top sirloin steak, was obtained fresh 
from a local supermarket. All visible fat and connective tissue was removed and the 
remaining lean meat was cut into small thin pieces, placed in 450 mL boiling water, and 
simmered for 30 min. After chilling overnight, all visible fat was removed, additional water 
was added, and the sample homogenized in an Osterizer® blender (Sunbeam-Oster 
Household Products, Laurel, MS) for 5 min. The slurry was then rehomogenized using a 
Polytron PT-3000 Homogenizer for 5 min at 25,000 rpm with a PT-DA 3012/2S generator 
(Brinkmann Instruments, Westbury, NY). The slurry was lyophilized in ziploc bags and the 
resulting powder passed through a 40-mesh sieve. Total protein of the powder was 
determined by a micro-Kjeldahl procedure (AOAC 1996). Total iron was determined by dry 
ashing and the iron measured by flame atomic absorption spectrophotometry (Allied 
Analytical Systems, Waltham, MA). Nonheme iron in the meat powder was determined by 
the modified method of Torrance and Bothwell (1968) using ferrozine instead of 
bathophenanthroline disulfonic acid as the ferrous chromogen (Chidambaram et al., 1989). 
In Vitro Digestion. Twenty grams of lyophilized beef powder was rehydrated with 110 
mL water and the slurry was rehomogenized again using a Polytron Homogenizer for 45 s at 
18.000 rpm with a PT-DA 3007/2 generator (Brinkmann Instruments, Westbury, NY). The 
pH of the homogenate was slowly adjusted to 2.0 with 5 mol/L HCl (Fisher Scientific, Fair 
Lawn, NJ) and 4 mL pepsin solution [0.08 g pepsin (2,800 U/mg protein) per mL 0.1 mol/L 
HCl] was added. The solution was then incubated for 1 h at 37°C in a shaking waterbath 
(Precision Scientific, Chicago, IL) at 90 rpm to simulate gastric digestion. Following 
incubation, the pH was slowly raised to 6.0 by the dropwise addition of NaHC03 (1 moL/L), 
and 20 mL pancreatin solution [0.004 g pancreatin (4 X U.S.P. activity) per mL 0.1 mol/L 
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NaHCOj] was added. Tne sample was then incubated for 30 min at 37°C in a shaking water 
bath at 90 rpm to mimic duodenal digestion. The homogenate was then removed from the 
water bath, chilled on ice, and centrifuged at 4°C for 30 min at 10,200 x g (Beckman 
Instruments, Palo Alto, CA) to collect the supernatant. Protein concentration (Lowry et al. 
1951) and nonheme iron concentration (Torrance and Bothwell 1968) of the digest 
supernatant was then measured. 
Ultrafiltration. The digest supernatant was subjected to sequential ultrafiltration in an 
Amicon stirred-cell unit (Model 8200, SUC 200 ml; Amicon. Inc., Beverly, MA) above a 
magnetic stirrer using first lOK and then followed by IK molecular weight cutoff (MWCO) 
membrane disks (Omega™, low protein-binding modified polyethersulfone; Pall/Gelman 
Sciences. Ann Arbor, MI) at 4°C under nitrogen at 55 psi. To achieve sufficient filtration. 
150 mL nanopure analytical grade water, 18.0 MQ-cm (Bamstead/Thermolyne, Dubuque. 
lA), was added to resuspend the remaining solution after 90% of the total volume of each 
solution had filtered. This was repeated three times per membrane. The three fractions 
collected were a 10-kDa retentate (lOKR), 1-kDa retentate (IKR), and I-kDa filtrate (IKF). 
Immobilized Metal Affinity Chromatography (IMAC). The procedure is similar to that 
described by Lonnerdal et al. (1977) and briefly described below. A column bed (10 x 2.5 
cm) of chelating sepharose consisting of highly cross-linked agarose beads coupled to imino­
diacetic acid (Amersham Pharmacia Biotech, Piscataway, NJ) was prepared by packing 50 
mL gel in a glass column and equilibrating with three column volumes water. The gel was 
then charged with approximately 20 mL of O.l moI/L CuS04-5H20. The column was then 
washed with five column volumes of nanopure water prior to equilibration with five column 
volumes of start buffer (0.02 moI/L Na2HP04 (Fisher Scientific, Pittsburgh, PA) and 1.0 
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mol/L NaCl at pH 8.1. Twenty mL of sample (IKR) solution (12.5 mg protein per mL start 
buffer) was applied to the column and washed with at least five column volumes of start 
buffer until the effluent had shown no absorbance at 280 nm. The wash was also collected to 
assure that no proteins of possible interest were lost. Adsorbed proteins were eluted by 
lowering the pH using elution buffer (0.02 mol/L Na2HP04 and 0.5 mol/L NaCl) at pH 3.0. 
Solutions for use in [MAC and in each of the following steps were prepared using nanopure 
water. 
Trace Metal Removal. The IMAC wash and eluents fractions were made metal-free with 
Chelex®-100 (200-400 mesh, sodium form; Bio-Rad Laboratories, Hercules, CA) resin 
treatment prior to amino acid composition analysis since even trace amounts of metals may 
interfere with the detection of some amino acids. Treatment was performed on an orbital 
platform shaker (Fisher Scientific, Fair Lawn, NJ) set at 120 rpm for 1 h. Fractions were 
then centrifuged at 4°C for 30 min at 10,200 g (Beckman Instruments. Palo Alto, CA) to 
collect the supematants. 
Concentration and Desalting. Microsep"""^ l-kDa MWCO centrifiigal devices 
(Omega^""', low protein-binding modified polyethersulfone; Pall/Gelman Sciences, Ann 
Arbor, MI) were used to simultaneously concentrate and desalt the IMAC wash and eluent 
fractions. Samples were centrifuged at 4°C for 30 min at 7,500 x g (Beckman Instruments, 
Palo Alto, CA). To achieve sufficient concentration and desalting of each sample, once 90% 
of the volume had filtered, nanopure water was used to resuspend the remaining solution, 
which was then recentrifuged. This process was repeated five times per sample. 
Cell Culture. Caco-2 cells were purchased at passage 17 from American Type Culture 
Collection (Rockville, MD). Experiments were conducted at passages 33-36. Cells were 
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grown in Dulbecco's Modified Eagle Medium with 10% fetal bovine serum, 1% nonessential 
amino acids (Gibco BRL, Grand Island, NY), and 1% antibiotic-antimycotic solution (Gibco 
BRL, Grand Island, NY). Cells were maintained at 37°C in an air incubator with 5% COz-
Media was changed every 3 d. Once reaching 80-100% confluence, the cells were rinsed 
with Earle's Balanced Salt Solution (EBSS; Gibco BRI., Grand Island, NY), dissociated 
using trypsin-EDTA (Gibco BRL, Grand Island, NY), and centrifuged for 6 min at 22.6 x g 
(Fisher Scientific, Fair Lawn, NJ). Cells were then seeded in a 75-cm" culture flask (Coming 
Costar Corporation. Cambridge, MA) at a density of 5,600 cells/cm" for continued growth. 
For iron uptake experiments, the cells were seeded onto collagen-treated 24-well cluster 
plates with 15.5 mm diameter (Coming Costar Corporation, Cambridge, MA) at a density of 
50,000 cells/cm". Collagen treatment of the 24 wells was performed by adding 40 (iL of 
3.76% NaCl to 1 mL of a purified collagen stock solution [40 ^g collagen (Type I Rat Tail 
Collagen; Collaborative Biomedical Products, Bedford, MA) per mL sterile deionized water] 
per well (Methods in Enzymology, 1979). The 24-well plate was then placed in the air 
incubator with 5% CO2 overnight (-18 h). After incubation, the collagen solution was 
removed and the plate was allowed to dry under sterile conditions immediately prior to use. 
Cells were used for iron uptake experiments at 14-15 d post-seeding (Glahn et al. 1997). To 
confirm that total cellular protein content in each of the 24 wells did not vary, cell 
monolayers were solubilized in 0.5 mol/L NaOH (Fisher Scientific, Fair Lawn, NJ) and 
sonicated using a sonic dismembrator (Fisher Scientific, Pittsburgh, PA) at a setting of 2. 
The protein concentration of the sonicated solutions was then determined (Lowry et al., 
1951). 
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Cell Uptake Procedures. Uptake solutions were prepared in EBSS with 10 mmol 
MES (2-[4-morpholino]-ethane sulfonic acid; Fisher Scientific, Fair Lawn, NJ) buffer at pH 
6.0 immediately prior to use. Uptake solutions containing 20 fimol/L Fe were prepared by 
adding a defined amount of ferric chloride (FeCl3-6H20, 1 mmol/L in 10 mmol/L HCl) to 
EBSS/MES with either ascorbic acid (ASC) (ferric:ascorbate; 1:20 molar ratio), 
nitrilotriacetic acid (NTA) (ferriciNTA; 1:5 molar ratio), no added ligand (blank), or test 
solutions (1 or 2 mg of beef protein per mL). The ASC was used as a positive control, NTA 
as a negative control, and FeClj only as the blank. Test samples refer to the digestate 
supernatant (DS), lOlCR, IKR, IKP, IMAC wash, or IMAC eluent fractions (peaks 1-4). 
Radioactive iron was purchased as ^''FeCb (DuPont/NEN, Boston, MA) and a trace amount 
(0.48 ng of Fe containing 277.5 Bq of'^'^Fe in 10 mmol/L HCl) was added to each of the 
uptake solutions, which were then immediately vortexed and used in the cell uptake 
procedures. 
Measurement of radioiron uptake was performed by modification of the method outlined 
by Glahn et al. (1997) with EBSS/MES at pH 6.0 instead of HBSS/PIPES (piperazine-N,N'-
bis-[2-ethanesulfonic acid]) at pH 6.7. Fifteen days after seeding, growth medium was 
removed from each well and the cell monolayers rinsed twice with 500 ^.L of EBSS/MES at 
37°C and pH 6.0. A 300 ^L aliquot of ^ ''Fe cell uptake solution was then placed on the cell 
monolayer and another 300 ^L aliquot was used to measure initial radioactivity. The 
monolayers were then placed in an air incubator at 37°C with 5% COi for 1 h. After 
incubation, iron uptake was terminated by removing the uptake solution and immediately 
rinsing the monolayers three times with 500 |iL of stop solution (140 mmol/'L NaCl, 5 
mmoI/L KCl (Fisher Scientific, Fair Lawn, NJ), and 10 mmol/L MES) at 20°C and pH 6.0. 
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Nonspecifically bound iron was removed using the method described by Glahn et al. (1998). 
After the cells were rinsed again with stop solution, monolayers were solubilized in 1 mL of 
0.5 mol/L NaOH and placed in scintillation tubes for '^Fe counting using a gamma 
scintillation counter (Auto-Gamma^^'; Packard Instrument Company, Meriden, CT). Total 
radioactivity was measured in all of the solutions. Percent "''pe recovery was measured with 
respect to its initial radioactivity. 
Solubility Assays. Iron solubility was also measured in the uptake solutions. After 300 
HL was applied to the cell monolayer, 1.2 mL of each cell uptake solution containing ^''pe 
was placed into a microcentrifuge tube and incubated for 30 min at ambient temperature. 
Samples were then centrifuged for 15 min at 15,000 x g using a microcentrifuge (Brinkmann 
Instruments, Westbury, NY). A 500 portion of the supernatant was used for radioisotope 
counting. Percent solubility was calculated with respect to iron (20 jimol/L FeCb in 10 
mmol/L HCl) solubility at pH 2.0. 
Electrophoresis. Separation of proteins and peptides present in the digest supernatant, 
ultrafiltration fractions, and the IMAC wash and eluent fractions was performed by sodium-
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using Tris/Tricine/SDS 
buffer (Bio-Rad Laboratories, Hercules, CA). A precast gel consisting of 10-20% Tris-
Tricine (NOVEX, San Diego, CA) was used for the digest supernatant and ultrafiltration 
fractions. A precast gel consisting of 16.5% Tris-Tricine (Bio-Rad Laboratories, Hercules, 
CA) was used for the IKR and IMAC wash and eluent fractions to ensure detection and 
separation of the smaller molecular weight proteins. Low range (Bio-Rad Laboratories, 
Hercules, CA) and ultra-low range SDS-PAGE molecular weight markers were used for 
molecular weight estimations ranging from 1- to 100-kDa. Following electrophoresis, the 
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gels were rinsed for 10 min in DI water. Gels were then fixed in freshly prepared 5% 
glutaraldehyde (Electron Microscopy Sciences, Ft. Washington, PA) for 1 h and washed for 5 
min three times using DI water. The gels were stained using 0.025% Coomassie Brilliant 
Blue G-250 (Eastman Kodak Company, Rochester, NY) in 10% acetic acid (Fisher 
Scientific, Fair Lawn, NJ) for 1 h. Destaining was done using 10% acetic acid (Fisher 
Scientific, Fair Lawn, NJ) overnight with several changes of this solution during the period. 
Matrix Assisted Laser Desorption lonization-Time of Flight (MALDi-TOF) Analysis. 
The MALDI-TOF mass analysis was performed to determine the molecular weight(s) of 
components in the IMAC wash and eluents. Test solutions were comprised of I jiL sample 
solution (50 pmol protein per i^L) mixed thoroughly with 24 (j.L of matrix solution (10 ng of 
a-cyano-4-hydroxycinnamic acid per mL). One ^L of the test solution was then applied to 
the target region of the sample grid and allowed to crystallize. The MALDI-TOF analysis 
was performed using a Voyager - DE PRO (Perseptive Biosystems Inc./Perkin Elmer. Foster 
City. CA). Spectra were acquired at 50 shots/spectrum and a mass range of 0.5- to 20-kDa. 
Data Explorer software (version 3.4; Perseptive Biosystems, Inc.) was used to analyze the 
data. 
Amino Acid Composition Analysis. The complete amino acid composition of the IMAC 
wash and eluents (PI-4) was determined at the University of Iowa (Molecular Analysis 
Facility, Iowa City, lA). Performic acid oxidation and hydrochloric acid hydrolysis were 
performed prior to anion-exchange analysis. Twenty nL of the IMAC wash or eluent sample 
solution (protein was 2 mg per mL for IMAC wash and 4 mg/mL for PI-4 in DI water) was 
used prior to evaporation. Norleucine was added to each sample as an internal standard. 
Samples were reconstituted with 100 jiL of 6 N HCl and the dead air space purged with 
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argon gas to displace atmospheric oxygen before placing samples in an oven at 110°C for 24 
h. Vacuum-evaporation was used to remove residual acid and the hydrolysates redissolved in 
sodium citrate diluent. Ion-exchange analysis (Beckman Instruments, Palo Alto, CA) was 
done with post-column derivatization using ninhydrin with separation on a 12 cm hydrolysate 
column using sodium citrate buffer in combination with a 3-step temperature program. 
Statistical Analysis. Data were analyzed using one way Analysis of Variance (ANOVA) 
and the differences among group means tested using Tukey's multiple comparison test 
(Prism software, version 2.01; GraphPad Software Inc., San Diego, CA). The mean 
differences were considered statistically significant at P < 0.05. Unless otherwise noted, 
values are expressed as mean ± SEM. 
RESULTS 
The cooked, lyophilized beef powder contained 90.0 ± 0.2% (n=3) protein. 89.7 ± 3.4 
ppm (n=2) total iron, and 32.7 ± 5.5 ppm (n=2) nonheme iron. Separation of the DS, lOKR, 
and 1 KJl by SDS-PAGE is shown in Figure 1. Preliminary results (data not shown) showed 
that the 1KF fraction was not detectable on the gel. 
Figure 1\ and 2B show iron (^''Fe) solubility and uptake, respectively, for the blank, 
ASC and NTA controls, and test solutions (2 mg protein per mL) from the DS and 
ultrafiltration fractions. The addition of ASC or NTA maintained iron solubility (87.5% and 
97.4%. respectively) at pH 6.0, whereas in the blank it was much less (8.7%). The presence 
of DS and the ultrafiltration fractions significantly (P< 0.001) improved iron solubility, 3 to 
8-fold when compared to the blank. Of the ultrafiltration fractions, the IKR maintained iron 
solubility at 43.8%, a significantly greater level than that of the lOKR (P < 0.05; 39.1%) or 
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1ICF (29.1 %; P < 0.001) fractions. Iron uptake by Caco-2 cells for the blank was low (8.6%). 
However, addition of ASC or NTA resulted in an increase (28.3%; P < 0.001) or decrease 
(3.1%; P > 0.05), respectively. In the presence of the IKR fraction, iron uptake was 22.8%, 
45.2%, and 56.5% greater than that of the DS, lOKR, and IKP, respectively, and 
approximately two-fold higher than the blank (P < 0.05) and five-fold higher than NTA {P < 
0.001). 
Based on our iron solubility and uptake results, only the 1 ICR was chosen for further 
analysis by IMAC, which yielded a series of four peaks: three distinct peaks (PI, P3, P4) and 
one with a few closely associated peaks (P2) (Fig. 3). Iron solubility and uptake by Caco-2 
cells in the presence of P1-P4 is shown in Figure 4A and 4B. Due to low yield. 1 mg protein 
per mL was used in all test solutions. Iron solubility in the presence of DS was significantly 
(P < 0.001) than the blank, resulting in a 3-fold increase (from 8.7% to 27.3%). The IMAC 
wash and P1-P4 all conferred significantly higher iron solubility than the blank; from two- to 
five-fold {P < 0.001 for P2-P4; P < 0.05 for PI). The addition of ASC or NTA resulted in an 
increase (18.0%) or decrease (2.7%) in iron uptake when compared to the blank. Iron uptake 
in the presence of P2 and P4 increased significantly (47.7% and 40.1%, respectively) when 
compared to 8.5% for the blank (f < 0.01 and 0.05 for P2 and P4, respectively). When 
compared to NTA, P1-P4 were found to enhance iron uptake by three- to five-fold {P < 
0.001). Although the IMAC wash increased iron solubility, it significantly (P < 0.01) 
decreased iron uptake by 60.5% when compared to the blank. 
Electrophoretic separation of the IKR and the IMAC wash and P1-P4 resulted in the 
detection of few distinct bands and revealed that each sample contained many peptides with 
molecular weights ranging from approximately 1- to 5-kDa (Fig. 5). Since the gel illustrated 
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that each sample was comprised of many peptides extremely close in size and shape, 
MALDI-TOF analysis was performed in an effort to distinguish the proteins. The MALDI-
TOF analysis of the EMAC wash and PI-P4 (Fig. 6A-D) demonstrated that peptides in each 
sample differ minimally in size. Amino acid analysis (Table 1) revealed that histidine 
concentration was 14 to 32 times lower in the IMAC wash than in P2 to P4 and that it 
increased progressively from PI to P4; ranging from 1.2 to 16.0 Mol%. Figure 7 shows the 
relationship between histidine content and iron solubility and uptake in PI-P4. The content 
of cysteine was approximately three times greater in Pi (at 6.4 Mol%) than in the IMAC 
wash and P2-P4, whereas glutamine in the IMAC wash (at 20.1 Mol%) was approximately 
twice that of P1 -P4. Lysine content of P1 -P4 was 13 to 81 % greater than the IMAC wash. 
Glycine content of the IMAC wash and P1-P4 was similar (mean 8.7 Mol%. ranging from 8-
10 Mol%). 
DISCUSSION 
Identification of the factor(s) in meat that enhance nonheme iron absorption has been 
difficult since performing human studies for this type of investigation is often not an option 
due to the inconvenience and cost. Rat models are appealing for in vivo studies (Gordon and 
Godber 1989, Van Campen 1972), but extrapolation of iron absorption data from rats to 
humans is questionable since meat has shown no effect on nonheme iron absorption in rats as 
compared to humans (Reddy and Cook 1991). Other researchers have used equilibrium 
dialysis, as an in vitro method to assess iron bioavailability (Miller et al. 1981; Shen et al. 
1994), but bioavailability as based on solubility or dialyzability alone has been shown to not 
accurately reflect uptake by the intestinal mucosa (Gangloff et al. 1996; Miller and Bemer 
63 
1989). Iron uptake by Caco-2 cells offers a physiological means to measure iron absorption 
(Garcia et al. 1996; Glahn et al. 1996) and nonheme iron uptake by the cells has shown 
significant correlation to human iron absorption when many dietary factors are tested (Au 
and Reddy 2000). Based on the reliability of the Caco-2 cell system, we used this in vitro 
model to identify beef peptides that enhance nonheme iron bioavailability. 
The enhancement of nonheme iron absorption by meat may involve chelation and 
solubilization (Zhang et al. 1990). Solubility was suggested to be a useful tool in predicting 
the enhancement of nonheme iron absorption (Slatkavitz and Clydesdale 1988, Carpenter and 
Mahoney 1989), but our data show that iron solubility does not reliably predict its uptake or 
bioavailability. For example, the solubility of iron in the presence of NTA was higher than 
ASC, but radioiron uptake by Caco-2 cells was much higher with ASC than NTA. Because 
NTA is a strong chelator of nonheme iron, it maintains the solubility of iron but does not 
permit its transfer to the mucosa, whereas ASC reduces and complexes with nonheme iron 
and allows for its exchange and subsequent uptake. Kapsokefalou and Miller (1991) 
proposed that components in meat released after digestion also have a reducing capability, 
similar to ascorbic acid based on an increase in the concentration of ferrous iron. 
The influence of the IMAC wash and P2-P4 on nonheme iron solubility were not 
significantly different from one another or from DS. Our findings are in agreement with 
others who caution against the sole use of solubility as a predictor of iron absorption 
(Gangloff et al. 1996, Bemer and Miller 1985). The affinity of a compound for iron and the 
type of complex formed may be equally important in determining the effect on nonheme iron 
absorption. If bound tightly, donation of iron to the mucosal cell may not occur, whereas if 
weakly bound, iron may dissociate and precipitate at the pH of the small intestine. 
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The effect of meat on nonheme iron absorption may be due to peptides released during 
proteolytic digestion, which are hypothesized to increase the solubility of inorganic iron 
(Kane and Miller 1984, Slatkavitz and Clydesdale 1988). On the contrary, others have found 
that the factor in meat responsible for enhanced nonheme iron absorption may not be related 
to gastrointesinal digestion (Au and Reddy 1997, Carpenter and Mahoney, 1989). 
Preliminary data in our lab (data not shown) suggested that, although undigested meat may 
possess factor(s) capable of solubilizing iron, the concentration of their counterparts in the 
digested sample is much greater. Therefore, we utilized proteolytic digestion to more closely 
simulate the physiologic condition and to increase the yield of proteins of interest. Although 
our data supports the findings of Slatkavitz and Clydesdale (1988), showing that proteolytic 
digestion of meat may result in the enhancement of nonheme iron absorption, it does not 
exclude the possibility that in the absence of proteolytic digestion, such factor(s) may exist. 
We used copper as a ligand in [MAC based on the procedure described by Lonnerdal et 
al. (1977). Ferric iron forms polymers and precipitates within the optimal pH range that most 
proteins adsorb to the IMAC gel. Lonnerdal and Keen (1982) also used copper for purifying 
lactoferrin, an iron binding protein. Although use of IMAC did not produce separate peaks, 
it allowed us to separate peptides from the 1KR on the order of their affinity for copper. The 
solubility of iron increased from PI to P4, matching copper binding affinity, indicating that 
IMAC using copper is a valid method. 
Because proteins in the IMAC wash and P1-P4 were so similar in molecular weight 
(approximately 1- to 5-kDa), separation by gel electrophoresis and MALDI-TOF analysis 
could not be achieved. Since the sample was initially subjected to proteolytic digestion, this 
resulted in more closely associated protein fragments in the IKR, perhaps differing by only 
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one amino acid. Since even a few metal atoms bound to any of the protein fragments present 
in the IMAC fractions would have added considerable mass and since the presence of metals 
may interfere with amino acid analysis, they were treated with Chelex-100 to ensure that they 
were essentially metal free. 
Amino acid composition analysis shows that the tMAC wash and P1-P4 primarily differ 
in histidine, lysine, glutamine, and cysteine content. Of the amino acids that differed or 
showed a trend, histidine appears to be the best candidate for explaining the enhancement of 
iron solubility and radiorion uptake. Histidine increased progressively from PI to P4. This 
result was not surprising since the affinity of these peptides to copper depends primarily on 
histidine. However, as histidine content of the fractions increased the percentage of soluble 
iron also increased, with a plateau after P3. Radioiron uptake was also enhanced with P2 and 
P4. which had greater histidine content than the IMAC wash and P1. which did not enhance 
uptake. Although no effect of histidine has been found on human iron absorption (Layrisse 
et al. 1984), our results support a study showing that histidine and lysine increase radioiron 
absorption when tested in rats (Van Campen and Gross 1969). Of the six amino acids tested 
(histidine, lysine, methionine, glutamic acid, glutamine, and glycine), only histidine and 
lysine significantly increased ^^Fe absorption. The same researchers later demonstrated that 
histidine increased ^''pe retention, but only if ^ ''pe and histidine were mixed together prior to 
administering them to the rats (Van Campen 1972) indicating the preformed complex plays a 
role in the enhancement iron absorption. In addition, decarboxylated histidine no longer 
enhances iron absorption in rats (Van Campen 1973), providing compelling evidence that 
histidine is involved in the enhancement of nonheme iron absorption. The biochemistry of 
histidine includes a pivitol role in the active binding sites of a number of iron-containing 
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enzymes and proteins of biological importance. Histidine often participates with other amino 
acids, such as lysine within these sites. The interaction between histidine and lysine has been 
shown to be responsible for iron binding in lactoferrin (Nicholson et al. 1997) and transferrin 
(He et al. 2000) and substitutions for these amino acids decreases the affinity of these 
proteins for iron. 
Cysteine and reduced N-terminal cysteinyl-peptides have also been hypothesized to be 
responsible for the positive effect of meat on nonheme iron absorption (Taylor et al. 1986, 
Garcia et al. 1996; Glahn and Van Campen 1997). Taylor et al. (1986) found that oxidation 
of the sulfhydryl of cysteine and decreased human iron absorption. However, our data does 
not support the finding that cysteine enhances nonheme iron absorption. Methodological 
differences may be responsible for the differences among the results of other studies and 
ours. 
In conclusion, our results suggest that the enhancing effect of beef on nonheme iron 
absorption may partially be due to low-molecular weight peptides produced during 
gastrointestinal digestion and that histidine content may be important. Further study to 
determine how histidine may enhance nonheme iron absorption and whether it's influence 
depends on the presence of other amino acids or in a specific sequence would be useful to 
understand the mechanism involved in the enhancement of nonheme iron absorption by meat. 
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Lane 1: Low range molecular weight standards 
Lane 2: 22.5 ng digest supernatant 
Lane 3: 22.5 ^ig lOKR 
Lane 4: 22.5 ng IKR 
Lane 5: Ultra-low range molecular weight standards 
Figure 1. SDS-PAGE (10-20 % Tris-Tricine) of digest supernatant and ultrafiltration 
fractions lOKRand IKR. 
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B 
Figure 2. Iron solubility (A) and radioiron uptake by Caco-2 cell monolayers (B) in the 
presence of ferrous ascorbate (ASC) (Fe:ASC of 1:20 molar ratio), nitrilotriacetic acid 
(NTA) (Fe:NTA of 1:5 molar ratio), the digest supernatant (DS), and ultrafiltration 
fractions lOKR, IKR, and IKP. Blank consisted of FeCb in EBSS/MES buffer alone 
(pH 6.0). Iron solubility was expressed as percent soluble iron compared to that at pH 
2.0 using 0.01 N HCl. Each sample contained 20|iM iron at intestinal pH (6.0) and 2 
mg/ml protein. Bars (mean ± SEM, n=3 and n=6-9 for Fig. 2A and 2B, respectively) 
with different letters are significantly different at p<0.05 when tested by ANOVA and 
Tukey's multiple comparison. 
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Figure 3. TMAC elution profile of IKR showing collected fractions (3.5 mL/tube). 
Proteins were adsorbed at pH 8.1 and eluted by lowering the pH to 3.0 using phosphate 
buffer containing NaCl. 
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Figure 4. Iron solubility (A) and radioiron uptake by Caco-2 cell monolayers (B) in the 
presence of ferrous ascorbate (ASC) (Fe:ASC of 1:20 molar ratio), nitrilotriacetic acid 
(NTA) (Fe:NTA of 1:5 molar ratio), the digest supernatant (DS), and the IMAC wash and 
peaks #1-4 from the IKR fraction. Blank consisted of FeCls in EBSS/MES buffer alone 
(pH 6.0). Iron solubility was expressed as percent soluble iron as compared to that at pH 
2.0 using HCl. Each sample contained 20^M iron at intestinal pH (6.0) and 1 mg/ml 
protein. Bars (mean ± SEM, n=3-4 and n=6-12 for Fig. 4A and 4B, respectively) with 
different letters are significantly different at p<0.05 when tested by ANOVA and Tukey's 
multiple comparison. 
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Figure 5. SDS-PAGE (16.5 % Tris-Tricine) of IKR and IMAC wash and peaks #1-4. 
77 
1«100 
Figures 6. Matrix Assisted Laser Desorption lonization-Time of Flight (MALDI-TOF) 
analysis spectra of IMAC peaks #1-4 (A-D, respectively) from the IFCR fraction prepared 
using a a-cyano-4-hydroxycinnamic acid matrix. The IMAC wash spectrum was similar 
(data not shown, see Appendix E). 
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Table 1. Amino acid profile of [MAC wash and eluents from IKR. 
Mol % 
Amino Acid Wash Peak #1 Peak #2 Peak #3 Peak #4 
Cysteine^ 1.7 6.4 1.7 2.7 1.6 
Asx 13.7 11.4 10.0 10.0 11.1 
Methionine'' 1.9 1.4 1.7 1.8 1.1 
Threonine 5.5 4.6 6.8 5.0 3.8 
Serine 5.5 4.5 4.1 4.8 4.8 
Glx 20.1 13.4 14.3 11.8 9.5 
Proline 5.8 6.8 7.0 5.5 4.8 
Glycine 9.0 10.0 8.7 8.0 8.0 
Alanine 8.4 7.5 7.7 6.9 7.8 
Valine 5.6 5.6 6.7 6.1 4.2 
Isoleucine 3.9 4.3 4.7 3.5 2.8 
Leucine 6.5 5.8 6.7 6.3 6.3 
Tyrosine 1.5 1.3 1.2 2.4 1.6 
Phenylalanine 1.4 1.4 1.3 2.8 2.5 
Histidine 0.5 1.2 7.2 9.6 16.0 
Lysine 6.9 11.5 7.8 9.8 12.5 
Arginine 2.4 3.0 2.4 3.1 1.6 
^ Cysteic acid 
Methionine sulfoxide 
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Figures 7. Histidine (mol %), solubility, and ^''Fe uptake of IMAC P1-P4. 
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CHAPTER 3. IRON INDICES AND TOTAL ANTIOXIDANT STATUS IN 
RESPONSE TO SOY PROTEIN INTAKE IN PERIMENOPAUSAL WOMEN 
A paper to be submitted to American Journal of Clinical Nutrition 
James H. Swain", D. Lee Alekel', Sarah B. Dent', Charles T. Peterson", Manju B. Reddy' 
Running Head: Total antioxidant and iron status during menopause 
ABSTRACT 
Background: Increased iron stores, oxidative stress, and estrogen deficiency place 
postmenopausal women at greater risk for heart disease and cancer. 
Objective: To determine the effect of soy protein isolate (SPI) intake on iron indices and 
plasma total antioxidant status (TAS), and determine the influence of other factors on TAS in 
perimenopausal women. 
Design: Perimenopausal women (N=69) were randomly assigned (double-blind) to 
treatment: isoflavone-rich soy protein isolate (SPI+; n=24), isoflavone-poor soy protein 
isolate (SPI-; n=24), or whey protein (control; n=21). Each subject consumed 40 g soy or 
whey protein/d for 24 weeks. Plasma TAS, serum ferritin, serum iron, transferrin saturation, 
and hemoglobin were measured at baseline, week 12, and week 24. 
' Department of Food Science and Human Nutrition, Iowa State University, Ames, lA 50011 
" Department of Statistics, Iowa State University, Ames, lA 50011 
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Results: Treatment per se had no significant effect on serum ferritin, serum iron, and 
transferrin saturation. Time had an effect on serum ferritin (f<0.0001) and TAS (P<0.0001). 
At week 12, TAS was lower (/^0.035) in controls than SPI+, whereas no significant 
differences were found between SPI+ and SPI- at week 12 or 24. Multiple regression 
analysis revealed that at week 12, baseline TAS, alcohol intake, soy intake (soy versus 
control; P=0.016), plasma Lp(a), and dietary iron contributed to the variability (48%; 
f^O.OOOl) in TAS. At week 24, 46% of the variability in TAS was contributed by baseline 
TAS, dietary meat, fish, and poultry (MFP) and zinc, serum ferritin and serum estrone. 
Conclusions: SPI consumption had no significant effect on iron status, but our results 
suggest that soy intake and decreased iron stores may protect fi-om oxidative stress in 
perimenopausal women. 
KEY WORDS antioxidant status, ferritin, iron indices, lipoprotein(a), menopause, 
soy protein isolate 
INTRODUCTION 
Ample information is available on the iron status of pre- and postmenopausal women, 
but the change in iron status that occurs during the menopausal transition, which may last for 
several years, has not been studied. In addition, the effect of changes in body iron stores on 
the total antioxidant status of women during the menopausal transition is also not known. 
Oxidative status typically decreases with age (Jayachandran et al. 1996), whereas body iron 
stores generally increase, especially in women after menopause (Berge et al 1994). High iron 
stores have been hypothesized to induce oxidative stress due to the ability of iron to catalyze 
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the Haber-Weiss reaction, which produces the hydroxyl radical. This radical is highly 
reactive with all biomolecules and is considered to be very toxic, causing structural damage 
to macromolecules, such as proteins and lipids and breakage of DNA strands (Santanam et al. 
1998). Generation of this radical in excess may deplete antioxidants (McCord 1993). This 
disturbance in the equilibrium between prooxidants and antioxidants may contribute to 
diseases, such as heart disease and cancer. Since epidemiological evidence suggests that 
increased iron stores place one at risk for developing heart disease (Salonen 1993; Kiechl et 
al. 1994) and cancer (Nelson et al. 1994), postmenopausal women may be at greater risk, 
similar to men (Sullivan 1981). Antioxidant defense systems, which include enzymes, 
plasma proteins, and dietary factors (Thomas 1999), react with radicals and minimize their 
damage (Halliwell 1993). These defense systems may be compromised during and after 
menopause and the concomitant increase in iron stores may increase such oxidative damage 
(Berliner and Heinecke 1996; Regnstrom et al. 1994). 
Soy protein isolate (SPI) is used extensively by the food industry, where it is 
incorporated into a variety of processed foods (Erdman and Fordyce, 1989). Soy protein 
isolate is known to markedly inhibit nonheme iron absorption (Cook et al, 1981; Gillooly et 
al. 1983) primarily because of its high phytic acid content (Hurrell et al. 1992) and the 
protein moeity (Lynch et al. 1994). Thus, diets poor in animal proteins that enhance iron 
absorption and diets rich in soy may be inadequate for maintaining optimal iron status in 
populations at risk for developing iron deficiency, but beneficial to groups at risk of 
developing excess iron stores. In addition, naturally occurring isoflavones in soy may have 
antioxidant properties because of their ability to donate hydrogen atoms and/or electrons 
from their hydroxyl groups to free radicals, making them less reactive (Mitchell et al. 1998). 
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However, the ability of these isoflavones in vivo to affect TAS during menopause has not 
been documented. We hypothesized that consumption of SPI during the menopausal 
transition may reduce the rate of menopause-associated increases in iron stores, thereby 
increasing antioxidant status in perimenopausal women. 
SUBJECTS AND METHODS 
Research design and treatment 
Perimenopausal women were recruited throughout the state of Iowa and bordering 
states. Subjects were included in the study if they met the following criteria: experiencing > 
10 hot flushes/wk, had irregular menses or menstrual period cessation, elevated follicle 
stimulating hormone (> 30 lU/L), a body mass index (BMI) between 20 to 31 (kg/m"), were 
free from chronic disease, not excessively exercising (< 10.46 MJ expenditure/wk), had one 
or both ovaries remaining, able to participate for 24 weeks, and willing to be randomly 
assigned to treatment. Exclusion criteria included chronic disease and/or routine use of 
medications, smoking, alcohol abuse, estrogen or hormone replacement therapy during the 
prior 12 months, or a history of eating disorders. Women started the study in one of four 
waves or cohorts begirming in January 1997, May 1997, September 1997, or March 1998. 
The study protocol and consent forms were approved by the Iowa State University Human 
Subjects Review Committee (IRB# 01; Assurance ID# Ml361). 
In this double-blind 24-week study, sixty-nine women were randomly assigned to one 
of three treatment groups: isoflavone-rich soy protein (SPI+; n = 24; Protein Technologies 
International; St. Louis, MO), isoflavone-poor soy protein (SPI-; n = 24; Protein 
Technologies International; St. Louis, MO), or whey protein (n = 21; Ross Laboratories; 
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Columbus, OH) control. The women were free-living and supplied with a total of 40 g 
protein/d, with half of this protein incorporated into a muffin and the other half as a powder 
that subjects incorporated into food or beverage. Since the muffin and powder provided 
approximately 2.09 MJ (500 kcal)/d, subjects were instructed to consume these as a meal 
replacement and not a supplement. Muffins were prepared in the Human Metabolic Unit of 
the Center for Designing Foods to Improve Nutrition at Iowa State University. To control for 
variability in supplement intake among subjects, each participant was provided with a single 
daily over-the-counter vitamin and mineral supplement (Spring Valley Sentury-Vite™, 
Leiner Health Products Inc.; Carson, CA) and instructed not to take any other vitamin and/or 
supplement and to avoid food items throughout the study with soy containing isoflavones not 
provided. 
Data collection 
As described in Alekel et al. (2000), anthropometric measures, fasted blood draws, 
and 24-hour urine samples were collected for each subject at baseline, week 12, and week 24. 
Anthropometry data included measurement of height (using a stadiometer) and weight (using 
a balance beam scale [Health-o-meter, Inc.; Bridgeview, Illinois]). Dual-energy x-ray 
absorptiometry (QDR-2000+; Hologic, Inc.; Waltham, MA) was used to assess total body 
composition (lean and fat mass) by two trained researchers and the data analyzed using 
software (Version 7.10, 1992) provided by the manufacturer. 
Dietary intake was assessed at baseline, week 12, and week 24 using five-d food 
records. To assist the subjects in quantifying portion sizes, two-dimensional food portion 
visual aids (Nutritional Consulting Enterprises, Morgan/Posner, 1981; Framingham, MA) 
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were provided. The food records were analyzed by trained nutrition students using the 
Nutritionist IV computerized nutrient database program (Version 4.1, 1995; San Bruno, CA). 
Urine samples were aliquoted and frozen at -80°C for subsequent analysis of 
isoflavones (Fujicco, Inc.; Kobe, Japan) to monitor compliance. The serum and plasma from 
each blood draw was stored at -80°C until the serum ferritin, serum iron, transferrin 
saturation, lipids, serum reproductive hormones (follicle stimulating hormone, estrone, 17 P-
estradiol), and plasma total antioxidant status (TAS) were determined. Hemoglobin 
concentration was determined in whole blood using the HemoCue® (HemoCue, Inc.; Mission 
Viejo, CA) system immediately following blood draws. Serum ferritin concentration was 
determined using an enzyme-linked immunoassay kit (RAMCO Laboratories; Houston, TX). 
Plasma TAS was determined using an assay kit according to the manufacturer's 
(Calbiochem-Novabiochem Corporation; La Jolla, CA) guidelines. Plasma TAS is measured 
colorimetrically and relies on the ability of antioxidants in the sample to inhibit the oxidation 
of ABTS® (2,2'-Azino-di-[3-ethylbenzthiazoline sulphonate]) to 'ABTS®" by metmyoglobin 
(a peroxidase). Quest Diagnostics (St. Louis, MO), a certified clinical laboratory, performed 
the 17 P-estradiol, estrone, total cholesterol, LDL cholesterol, HDL cholesterol, and 
triacylglycerol measurements at each time point. LDL cholesterol concentrations were 
calculated using the Friedewald equation (Friedewald et al. 1972): (total cholesterol) - (HDL 
cholesterol) - (triacylglycerol/5). Plasma Lp(a) was analyzed at the University of Illinois at 
Chicago (Hematology and Coagulation Laboratory). Plasma Lp(a) [TintElize®Lp(a)] 
concentrations were measured at baseline, week 12, and week 24, using an 
immunoenzymetric method with affinity purified polyclonal antibodies against Lp(a), 
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according lo the manufacturer's (Biopool, Intemationai; Ventura, CA) guidelines. Lp(a) 
concentrations were read using an automated microtiter plate reader (EL31 Isx, Bio-Tech 
Instruments, Inc.; Winooski, VT). 
Statistical analyses 
Statistical analyses were performed using SAS (Version 8.0, 1999; Cary, NC); results 
were considered statistically significant at P<0.05. Descriptive statistics include means for 
normally distributed data (age; body size and composition; serum iron and serum transferrin 
saturation) and medians for not normally distributed data (dietary intake of nutrients; serum 
ferritin; total serum cholesterol, triacylglycerol, LDL and HDL cholesterol, and Lp(a); 
estrone and 17 p-estradiol). Women with serum ferritin values of zero were assigned 0.5 
fig/L for statistical purposes; exclusion of this data would have resulted in reduced statistical 
power. Repeated measures ANOVA was used to determine the effect of treatment on plasma 
TAS, serum ferritin, serum iron, transferrin saturation, and hemoglobin. Residual analysis 
indicated non-constancy of error variance (it increased with greater Y, values) for the 
triacylglycerol, HDL cholesterol, and Lp(a) regression models. Thus, values for these 
measures were log-transformed for the repeated measures ANOVA and regression analyses. 
Log-transforming triacylglycerol, HDL cholesterol, and Lp(a) for the regression models 
markedly improved the residual plots. Stepwise multiple regression was used to determine 
the effect of contributors to plasma TAS at week 12 and week 24. Classes of variables in 
modeling plasma TAS at weeks 12 and 24 included baseline values for age, body 
size/composition (weight, lean mass, fat mass or percent body fat), dietary factors (total fat, 
polyunsaturated fat, alcohol, meat [beef, lamb, and pork], fish, and poultry (MFP), vitamin 
A, vitamin C, vitamin E or alpha-tocopherol, iron, and zinc), iron indices (serum iron and 
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serum ferritin), and serum estrogens (17 P-estradiol and estrone). Violation of model 
assumptions was not evident, since residual analyses indicated that the model assumptions of 
independence of residuals, normality of error terms, and homogeneity of residual variance 
were satisfied for these regression models. No notable multicollinearities emerged among 
the independent variables, as indicated by the low variance inflation factors in the regression 
analyses. 
RESULTS 
Compliance 
Compliance was based on reported intake by the women and corroborated by the 
urinary excretion of isoflavones (Alekel et al. 2000). Eighty seven percent of the women (60 
of 69 women) reported consuming 100% of the muffins and 84% (58 of 69) reported 
consuming 100% of the powder throughout the study. One woman's data fi-om the control 
group was removed from all analysis because her urinary e.xcretion of isoflavones during the 
treatment period was similar to that of subjects in the isoflavone-rich soy group. 
Baseline measures 
Baseline characteristics of the women are presented in Table 1, which includes 
anthropometric measures, dietary intake of selected nutrients, and serum measures. Since the 
characteristics at baseline were not significantly different among the three treatment groups, 
reported mean or median values represent all the women in the study. Alcohol intake and 
serum estrogens varied widely among subjects (Table 1). 
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Iron indices and antioxidant status 
Serum iron and transferrin saturation declined from baseline to week 24 in the SPI+ 
and SPI- groups, whereas these iron indices increased in the control group (Table 2). The 
mean serum iron concentration was 14.7 ^imol/L in the control group as compared to the 
groups consuming soy (SPI+ nmoLAL = 16.4 and SPI- = 16.9 nmol/L), but the three groups 
had similar mean concentrations at the end of the study (14.6 to 15.0 lamol/L). By week 24, 
serum iron concentration decreased by approximately 11% from baseline in the two groups 
consuming SPI compared to a small increase of 2% in the control group. Similarly, 
transferrin saturation decreased by 2.6 to 7.2% from baseline in the two groups consuming 
SPI, whereas an increase of 9.5% was observed in the control group. 
Treatment also did not affect hemoglobin, serum ferritin, and plasma TAS (Figure 1). 
Plasma TAS and hemoglobin values are presented as mean ± SEM, whereas serum ferritin 
values were not normally distributed and thus are presented as median, with the 25''' and 75''^ 
percentile bars indicating variability. Figure 1 illustrates that time had a significant effect on 
hemoglobin (P=0.004), serum ferritin (P<0.0001), and plasma TAS (f^O.OOOl). Although 
the control group had a lower mean hemoglobin value than the groups consuming SPI, the 
differences were not significantly different and at week 24 the groups had similar values. 
Hemoglobin increased only in controls, possibly because of the marginally lower (albeit NS; 
P=0.052) values these subjects had at baseline. The serum ferritin value for each group 
generally increased by week 24, but there were no significant differences among the groups 
during the study. At week 12, plasma TAS was significantly lower (P=0.035) in controls 
than SPI+, but these differences did not remain significant at week 24 (P=0.057). No 
significant differences were found between SPI+ and SPI- either at week 12 or 24. 
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Since TAS was influenced significantly by treatment at week 12, we further explored 
the relationship between the factors in Table 1 and iron indices with plasma TAS. Since both 
soy treatments (SPI+ and SPI-) were not significantly different, these groups were combined 
for the regression analysis using contrast coding. In this context, "soy" refers to SPI+ and 
SPI- contrasted with the control group. Factors contributing to plasma TAS at week 12 and 
week 24 are presented in Table 3. In the regression model for week 12, the only significant 
treatment contrast (soy versus control; P=0.016) indicated that plasma TAS was affected 
positively by soy protein rather than by isoflavones. Other contrasts were not significant. At 
week 12, baseline plasma TAS, alcohol intake, soy intake, plasma Lp(a), and dietary iron 
accounted for 48% of the variability (P^O-OOOl) in TAS. However, at week 24, baseline 
plasma TAS, dietary MFP and zinc, serum ferritin and serum estrone accounted for 46% of 
the variability in plasma TAS. A key finding was that at both weeks 12 and 24, baseline 
TAS was an important (P<0.0001) contributor to plasma TAS. 
DISCUSSION 
At baseline, 13% of all the women were anemic (hemoglobin < 12 g/L), compared to 
7% by week 24, suggesting that the incidence of anemia was reduced during the menopausal 
transition. This is particularly true in the control group (Figure 1). The increase in 
hemoglobin observed among control subjects may have been attributable to their lower 
baseline values compared to the other two groups. Regardless of treatment, there was a trend 
toward increased serum ferritin values, consistent with other studies (Berge et al., 1994; 
Penckofer and Schwertz 2000), showing age- and/or menopause-associated increases in 
serum ferritin. The increase in serum ferritin may have been due to decreased iron losses via 
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menstruation secondary to hormonal changes (Milman et al., 1992). Alternatively, the 
increase may have been influenced by the overall lower mean serum ferritin values observed 
in our study at baseline (28.6 ng/mL) compared to values reported by other researchers (Pilch 
and Senti 1984, Penckofer and Schwertz 2000). In our study, serum iron and transferrin 
saturation decreased with soy consumption, regardless of its isoflavone content, suggesting 
that the decrease in iron status may have been due to the inhibitory effect of phytic acid 
(Reddy et al. 1996) or the protein moiety itself (Lynch et al. 1994) on nonheme iron 
absorption. However, the decrease in these iron indices was not significant, possibly due to a 
relatively small sample size. 
Oxidative status depends on the balance between proo.xidants, such as iron, and 
antioxidants, such as enzymes, plasma proteins, and dietary factors (Rice-Evans and Burdon 
1993). Plasma TAS is an overall indicator of oxidative status. Women in our study had 
baseline plasma TAS values ranging from 0.53 to 0.68 mM, apparently lower than values 
previously reported (1.3 to 1.8 mM) in humans (Miller et al. 1993). Because of the 
difference between the SPI+ and control group in plasma TAS at week 12, we performed a 
multiple regression analysis at weeks 12 and 24 to determine factors that may have 
influenced plasma TAS. Baseline plasma TAS, soy consumption, and alcohol intake 
favorably contributed to plasma TAS at week 12. The finding that baseline TAS had such a 
favorable association illustrates that women who began the study with higher plasma TAS 
maintained this status throughout the study. Soy intake, irrespective of isoflavone content, 
had a beneficial effect on TAS, perhaps in part because phytic acid is an antioxidant (Graf 
and Eaton 1990; Ko and Godin 1990) and/or because both phytic acid (Reddy et al. 1996) 
and the protein moiety (Lynch et al. 1994) reduce nonheme iron absorption, possibly 
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attenuating iron stores. The positive effect of alcohol on plasma TAS may have been due to 
the polyphenol content of alcoholic beverages. Phenolic compounds have been shown to 
have an antioxidant effect, as illustrated by their ability to inhibit the oxidation of human 
LDL in vitro (Frankel et al. 1995). The positive relationship of dietary MFP to TAS at week 
24 may be related to the antioxidant properties of conjugated linoleic acid, the only known 
antioxidant associated primarily with animal foods (Pariza et al. 2000). Conjugated linoleic 
acid has been shown to inhibit free radical generation (Steinhart 1996), thereby providing a 
plausible explanation for the favorable effect we found of MFP on plasma TAS. 
Plasma lipoprotein(a) and dietary iron were negatively associated with TAS at week 
12, but not at week 24. Lipoprotein(a) is of increasing interest since it is considered both a 
marker of thrombotic and of atherosclerotic risk (Dobroski and Loscalzo 1996). Hormonal 
changes that occur during menopause may elevate lipoprotein(a) (Mijatovic et al. 1997). 
Elevated lipoprotein(a) concentrations are associated with an increased risk of atherosclerotic 
cardiovascular disease, a disease known to be associated with lipid peroxidation. This 
association may exist because greater lipoprotein(a) concentrations may provide more 
abundant substrate for reaction with radicals, which in turn may burden the antioxidant 
system, thereby decreasing plasma TAS. The inverse relationship between dietary iron and 
TAS is suggestive of the role of iron as a prooxidant, shown to promote lipid peroxidation in 
vitro (McCord 1993). Serum ferritin, serum estrone, and dietary zinc were negatively related 
to plasma TAS only at week 24. Our data support epidemiological studies showing an 
inverse relationship between serum ferritin and oxidative status and that lower iron stores 
may protect from oxidative stress (Berge et al. 1994; Keichl et al. 1994). The negative 
relationship between serum ferritin and plasma TAS may have reflected the overall increase 
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in iron stores by week 24 in these perimenopausal women, which may have been age- and/or 
menopause-related. Although we could not distinguish between an age- or menopause-
related effect on iron stores, this latter idea is strengthened by the negative relationship 
between serum estrone and TAS in the regression model, since serum estrone may influence 
iron stores, and by finding that serum estrone increased (P<0.0001) overall during the course 
of the study. The observation of increased serum estrone during our study may have been 
due to their relatively high fat mass (—37%) throughout the study. Adipose tissue is a 
primary site for peripheral aromatization of adrostenedione to estrone (Nordin 1981). Thus, 
we speculate that the increase in serum estrone may have reflected adipose tissue conversion 
from adrostenedione, and that the inverse relationship between estrone and TAS simply 
mirrored changes due to the menopausal transition. Although physiological doses of 17 p-
estradiol have been shown to inhibit lipoprotein oxidation (Sack et al. 1994), estrone has not 
been shown to have antioxidant properties. 
In contrast, it was surprising to observe an inverse relationship between dietary zinc 
and plasma TAS because zinc is an essential cofactor for many antioxidant enzymes, such as 
superoxide dismutase. Since zinc also binds to phytic acid (Zhou and Erdman 1995), dietary 
zinc competes intraluminally with iron (Solomons el al. 1983) for binding sites on phytic 
acid, which may have resulted in a greater proportion of iron available for absorption. Thus, 
as dietary zinc increases it may allow for greater nonheme iron absorption, thereby increasing 
serum ferritin and decreasing TAS. This hypothesis is consistent with the inverse 
relationship between dietary iron and TAS at week 12 and serum ferritin and TAS at week 
24. 
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In conclusion, treatment had no significant influence on iron indices during the 24-
week study period, but soy intake had a beneficial effect on TAS at week 12 in these 
perimenopausal women. Our data suggest that lower iron stores and soy protein isolate, 
regardless of its isoflavone content, may enhance antioxidant status. However, there may 
also be other factors that we did not assess, but influence iron status and play a major role in 
determining TAS in perimenopausal women. Our data also indicate that some 
perimenopausal women had low serum ferritin and may not yet be at risk of compromised 
oxidative status associated with higher iron stores typically found in postmenopausal women. 
In addition, women entering menopause with greater TAS were more likely to maintain this 
status throughout the study. These subjects were a self-selected group of mid-life Iowa 
women seeking an alternative to traditional hormone replacement therapy. Thus, we must be 
cautious in applying the results of this small-scale study to perimenopausal women in 
general. Future studies are needed to explore preventative measures aimed at controlling 
menopause- and age-related increases in body iron, thereby maintaining optimum TAS. 
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Figure Legend 
FIGURE 1. Concentrations of plasma total antioxidant status (TAS; mean ± SEM), serum 
ferritin (median; error bars indicate 25'*^ and 75''' percentiles since values are not normally 
distributed), and hemoglobin (mean ± SEM) are presented from baseline to week 24 in each 
of the three treatment groups of perimenopausal women: isoflavone-rich soy (SPI+ = •; n -
24), isoflavone-poor soy (SPI- •; n = 24), and whey (control •; n = 21) protein. Values 
were not significantly different among treatment groups at baseline. Repeated measures 
ANOVA indicated that there was a treatment effect only for hemoglobin (f^O.052) and a 
significant time effect on concentrations of hemoglobin (/*=0.004). serum ferritin 
(P<0.0001), and plasma TAS (P^O.OOOl). 
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TABLE 1 
Baseline characteristics' in perimenopausal women 
Measurement (n = 69) 
Age (years) 
Height (cm) 
Weight (kg) 
BMI (kg/m-) 
Lean mass (kg)' 
Body fat (%)' 
Dietary intake/d 3.4 
Vitamin E (mg) 
Alcohol intake (g)^ 
Iron (mg) 
Mean+SD 
(min-max) 
50.2+3.6 
(41.9-61.6) 
164.8+5.0 
(151.6-177.5) 
65.3+9.0 
(48.5-98.1) 
24.1+3.2 
(17.4-33.7) 
39.8+6.8 
(31.4-48.6) 
37.2+6.3 
(18.4-53.1) 
Median 
(min-max) 
10.7 
(1.5-29.7) 
162.1 
(0.8-1131.3) 
13.5 
(5.8-25.7) 
100 
TABLE 1 (continued) 
Zinc (mg) 8.4 
(2.8-43.9) 
Dietary MFP (serving)^ 1.2 
(0-2.5) 
Serum^ Median 
(min-max) 
Total cholesterol (010101/!.) 5.4 
(3.6-8.0) 
Triacylglycerol (mmol/L) 1.0 
(0.5-4.5) 
LDL cholesterol (mmol/L) 3.3 
(1.9-5.9) 
HDL cholesterol (mmol/'L) 1.5 
(0.9-2.9) 
Lipoprotein(a) (runol/L) 21.2 
(3.1-209.3) 
Estrone (pmol/L) 122.1 
(37.0-447.6) 
17 P-estradiol (pmol/L) 150.5 
(73.4-785.6) 
' These characteristics at baseline were not significantly different among the three treatment groups 
" Assessed by dual energy x-ray absorptiometry 
^ .Median values are reported for serum analytes and dietary intake, since most were not normally distributed 
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TABLE 1 (continued) 
^ Dietary intake was assessed from a 5-d food diary collected prior to baseline testing 
' Refers to 33 women who reported that they consumed alcohol while recording their food intake 
'* Refers to the collective contribution of meat (beef, lamb, and pork), fish, and poultry; 1 serving = 3 oz,'d 
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TABLE 2 
Transport iron indices of perimenopausal women at baseline, week 12, and week 24 
Serum Measure' 
Time 
(wk) 
SPI+-
(/i=24) 
SPI--
(11=24) 
Control" 
(/i=21) 
Treatment Time 
P value^ 
Iron (fimol/L) 0 16.9±6.2 16.4±6.2 14.7±5.2 
12 15.3±5.3 I5.1±6.9 14.7±4.8 
24 15.0±4.3 14.6±6.l 15.0±5.8 0.75 0.39 
% change"* -11.3 -11.0 +2.0 
Transferrin 
saturation (%) 0 29.2±10.6 27.0±11.6 26.2±10.1 
12 26.4±10.0 25.6±12.2 26.7±9.2 
24 27.1±7.7 26.3±10.6 28.7±9.4 0.94 0.64 
% change"* -7.2 -2.6 +9.5 
' Mean ± SEM 
' SPI- = isoflavone-rich soy protein isolate; SPI- = isoflavone-poor soy protein isolate; control = whey protein 
^ P values based on repeated measures ANOVA 
"* % change = week 0 - week 24/week 0 
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TABLE 3 
Regression analyses: Contributors to plasma total antioxidant status at week 12 and week 24 
Total Antioxidant Status at Weeic 12 
Overall Model R-=48.3% (Adj. R-=41.3%); F (8, 67) = 6.88;(P< 0.0001) 
Independent Variable Parameter 
Estimate 
Percentage 
Variance' P value' 
Variance 
Inflation^ 
Intercept 0.5638 
Total antioxidant status - baseline 0.5412 23.6 
0.0005 
<0.0001 1.15 
Alcohol intake^ 0.0125 5.7 0.013 1.21 
Soy vs. control' 0.0961 5.4 0.016 1.37 
Plasma lipoprotein(a)'* -0.0014 
Dietar\'iron"* -0.0130 
5.1 
2.6 
0.019 
0.091 
1.15 
1.63 
Total Antioxidant Status at Week 24 
Overall Model rM5.7% (Adj. R-=38.4%); F (8, 68) = 6.30; (P < 0.0001) 
Independent Variable Parameter 
Estimate 
Percentage 
Variance' P value" 
Variance 
Inflation^ 
Intercept 0.5634 
Total antioxidant status - baseline 0.4460 16.3 
<0.0001 
<0.0001 1.20 
Dietary MFP'^ ' 0.2234 10.3 0.001 1.29 
Serum ferritin' -0.0024 8.7 0.003 1.10 
Serum estrone' -0.0007 7.0 0.008 1.21 
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TABLE 3 (continued) 
Dietar\'zinc" -0.0253 4.9 0.024 1.13 
' Squared semi-partial Type II correlation coefficient; accounts for shared variance among variables 
' Variables left in models are significant at P < 0.05 level, except for dietary iron at P < 0.1 
^ Measures inflation in the variances of parameter estimates due to multicollinearities among regressors 
^ These independent variables reflect measures at week 12 
' SPI- plus SPI- vs. control 
" Refers to the collective contribution of meat (beef. lamb, and pork), fish, and poultry; 1 serving = 3 oz/d 
These independent variables reflect measures at week 24 
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CHAPTER 4. GENERAL CONCLUSIONS 
The objective of the first study was to isolate and characterize beef muscle proteins 
that enhance nonheme iron bioavailability. Our results suggest that the enhancing effect of 
beef on nonheme iron absorption may partially be due to low-molecular weight peptides 
produced during gastrointestinal digestion and that histidine content may be important. 
Further study to determine how histidine may enhance nonheme iron absorption and whether 
it's influence depends on the presence of other amino acids or in a specific sequence would 
be useful to understand the mechanism involved in the enhancement of nonheme iron 
absorption by meat. 
The objective of the second study was to determine the effect of soy protein isolate 
(SPI) intake on iron indices and plasma total antioxidant status (TAS), while accounting for 
the effect of other factors on TAS in perimenopausal women. Treatment had no significant 
influence on iron indices during the 24-week study period, but soy intake had a beneficial 
effect on TAS at week 12 in these perimenopausal women. Our data suggest that lower iron 
stores and soy protein isolate, regardless of its isoflavone content, may enhance antioxidant 
status. However, there may also be other factors that we did not assess, but influence iron 
status and play a major role in determining TAS in perimenopausal women. Our data also 
indicate that some perimenopausal women had low serum ferritin and may not yet be at risk 
of compromised oxidative status associated with higher iron stores typically found in 
postmenopausal women. In addition, women entering menopause with greater TAS were 
more likely to maintain this status throughout the study. These subjects were a self-selected 
group of mid-life Iowa women seeking an alternative to traditional hormone replacement 
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therapy. Thus, we must be cautious in applying the results of this small-scale study to 
perimenopausal women in general. Future studies are needed to explore preventative 
measures aimed at controlling menopause- and age-related increases in body iron, thereby 
maintaining optimum TAS. 
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APPENDIX A. ELECTRON MICROSCOPY 
Scanning Electron Microscopy (SEM): Caco-2 cell monolayer sections were fixed 
initially in 3% paraformaldehyde and 2%glutaraldehyde in 0.05 M sodium phosphate buffer 
(pH 7.2) for 24 hrs 4°C. Monolayer sections were then subjected to secondary fixation using 
1% osmium tetroxide in 0.05 M sodium phosphate buffer (pH 7.2) for 1 hr at room 
temperature. The sections were then washed with nanopure water, dehydrated in a graded 
ethanol series, and dried using a Denton DCP-1 critical point drying apparatus. Sections 
were then mounted on aluminum stubs and sputter coated using a Polaron SEM coating unit 
ES100 with a 60/40 palladium/gold target. Monolayer sections were viewed using a JEOL 
5800LV scanning electron microscope. Digital images were captured and stored using 
ARC58 software (JEOL, Japan) (Fig. 1A & B). 
Transmission Electron Microscopy (TEM): To facilitate sectioning, Caco-2 cell 
monolayer sections were fixed initially in 3% paraformaldehyde and 2%glutaraldehyde in 
cell culture media (10% fetal bovine serum, 0.82% amino acid solution, 0.82% 
antibiotic/antimycotic, 88.36% minimum essential media) (pH 7.4) for 24 hrs at 4°C. 
Monolayer sections were then subjected to secondary fixation using 1% osmium tetroxide in 
the cell media as described previously (pH 7.4) for 1 hr at room temperature. The sections 
were then washed with nanopure water, dehydrated in a graded ethanol series, and cleared 
with pure acetone prior to infiltration using EPON polyapoxy resin (Electron Microscopy 
Sciences, Fort Washington, PA). Sections 1 |im thick were prepared using a Reichert 
Ultracut-S and stained in 1% toluidine blue. Sections 50-70 nm were then collected on 200 
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mesh copper grids and stained for 20 min using 8% methanolic uranylacetate followed by 
SATO'S lead stain. TEM images were captured using a JEOL 1200EX dual SEM/TEM 
(JEOL, Japan) (Fig. 3 & 4). 
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Figure lA & IB. Scanning electron micrographs showing monolayer of confluent 
differentiated Caco-2 cells with dense surface villi at 2K and 15K x magnification. 
Figure 2. Transmission electron micrograph of Caco-2 cell monolayer at 5K x magnification. 
iipi 
Figure 3. Transmission electron micrograph of Caco-2 cell monolayer at 20K x magnification. 
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APPENDIX B. EFFECT OF TRITON X-100 ON THE YIELD OF SOLUBLE 
PROTEIN 
The cooked beef water extract supernatant and digest supernatant were both found to 
possess soluble proteins, which bound iron and enhanced iron uptake. However, we decided 
lo use the digest supernatant because protein yield was greater. To determine if the yield of 
soluble iron-binding proteins could be increased, we subjected two grams of the initial 
sediment to resuspension using detergent (25 mL of 4% Triton X-100; Sigma Chemical 
Company, St. Louis, MO). The slurry was then vortexed, allowed to incubate at ambient 
temperature for 20 min, and centrifiiged at 1380 x g for 25 min. Radioiron (^^Fe) was added 
during the incubation period and measured in the supernatant to assess the yield of soluble 
iron-binding proteins. The addition of 2 or 4% Triton X-100 resulted in the solubilization of 
9.7 and 15.7% of the total radioiron, respectively (Fig. 1). Findings show that addition of 2 
or 4% Triton X-100 to the initial sediment increased, slightly, the yield of soluble iron-
binding proteins, but not enough to warrant the routine use of the detergent. In addition, it 
would have been necessary to remove the detergent prior to use of the sample during the 
subsequent separation and uptake procedures. 
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Figure 1. Effect of resuspension of the initial beef sediment using 2% and 
4% Triton X-100 on recovery of ^ ''Fe. 
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APPENDIX C. SIZE-EXCLUSION CHROMATOGRAPHY 
Size exclusion chromatography of beef proteins precipitated at 80% saturated 
ammonium sulfate (NH3SO4) solution was performed using polyacrylamide gel beads 
(Biogel P60; BioRad Laboratories, Hercules, CA) having a nominal fractionation range of 
3.5- to 60-kDa. Chromatographic separation, using 20 mM 2-(4-morpholino)-ethane sulfonic 
acid (MES; Fisher Scientific, Fair Lawn, NJ) buffer at pH 5.4 and 5.5°C, revealed two 
distinct peaks (Fig. 1). Electrophoresis revealed that both peaks were comprised of many 
proteins ranging of varying molecular weight (data not shown). It was also found that salt 
was partially co-eluting with the later portion of the second peak. Since this procedure 
resulted in minimal separation of the components present in the 80% saturated NH3SO4 
fraction and because salt was found to partially co-elute with the second, more dominant 
peak, we decided to investigate other techniques to better separate the proteins. 
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Figure 1. Size exclusion chromatography of beef proteins precipitated at 80% saturated 
NH3SO4 solution performed using polyacrylamide gel beads with a nominal 
fractionation range of 3.5- to 60-kDa. Chromatographic separation was done using 20 
mM 2-(4-morpholino)-ethane sulfonic acid (MES) buffer at 5.5°C and pH 5.4. 
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APPENDIX D. EFFECT OF 2-(4-lVIORPHOLINO)-ETHANE SULFONIC ACID 
(MES) ON RADIOIRON UPTAKE AND TRANSPORT BY CACO-2 CELLS 
Radioiron uptake and transport by Caco-2 cells were found to be positively associated 
with MES concentration. The characteristics of MES are a pKa of 5.96 at 37°C and buffer 
range of pH 5.5 to 6.5. MES is considered to be the most useful buffer among 3,3-
dimethylglutamic acid, tricarballyic acid, trans-aconitic acid and HEPES in the pH range 5.0 
to 6.0 due to its biological inertness, buffering capacity, the minimal requirement for excess 
base to adjust pH, and its minimal metal complexing ability. The influence of MES was first 
observed when pooled size-exclusion chromatography fractions were lyophilized in order to 
obtain reasonable working protein concentrations and then used in an experiment designed to 
measure radioiron uptake and transport by Caco-2 cells grown on collagen treated 
membranes forming bicameral (apical and basal) chambers. To confirm the existence of the 
effect, an experiment was designed where only the MES concentration was varied in the 
presence of iron and nitrilotriacetic acid (NTA) (ferric:NTA; 1:5 molar ratio) with no beef 
sample. The MES concentrations used in this experiment matched those resulting from the 
earlier mentioned lyophilization process. A sample of 10 mM MES was also included. 
Results show that when the concentration of MES increases from 10 mM to 27 mM or 43 
mM Caco-2 cell radioiron uptake and transport increase (Fig. 1). The MES concentration in 
our uptake solutions was meticulously controlled for (see Chapter 2, ^''pe Cell Uptake 
Procedures). 
1 1 7  
• % uptake 
• % transport 
S % total uptake 
20 T 
10 mM 27 mM 43 mM 
MES concentration 
Figure 1. Effect of 2-(4-morphoIino)-ethane sulfonic acid (MES) on 
radioiron uptake and transport by Caco-2 cells grown on collagen treated 
membranes forming bicameral chambers. 
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APPENDIX E. MATRIX ASSISTED LASER DESORPTION lONIZATION-TIME 
OF FLIGHT (MALDI-TOF) ANALYSIS: THE IMMOBILIZED METAL CHELATE 
AFHNITY (IMAC) WASH 
The MALDI-TOF analysis of the IMAC wash was performed as described earlier 
(see Chapter 2, Matrix Assisted Laser Desorption lonization-Time of FHght (MALDI-TOF) 
Analysis). The IMAC wash spectrum was similar to the spectra of each eluent peak (P1-P4) 
( F i g .  1 ) .  
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Figure 1. Matrix Assisted Laser Desorption lonization-Time of Flight (MALDI-
TOF) analysis spectrum of the IMAC wash from the IKR fraction prepared using 
a a-cyano-4-hydroxycinnamic acid matrix. 
